Device usually used to quit or be an alternative to tobacco
POPULARITY
Jo Cheah talks with Eileen Cole, GP lead, and Jennifer Kyi, pharmacist advisor at Quit, about the use of therapeutic vapes for smoking cessation. They discuss the current evidence and new Australian guidelines. The conversation also covers choosing a vape and how to prescribe or supply vapes. Read the full article by Eileen, Jennifer, and their co-authors, in Australian Prescriber.
Já não faltavam evidências sobre os malefícios dos vapes e cigarros eletrônicos em 2019, quando falamos pela primeira vez sobre o assunto. Mas quais as novas evidências? E o seu consumo já se configura um problema de saúde pública?Este episódio é apresentado pela ACT Promoção da Saúde, organização não governamental que atua na promoção e defesa de políticas de saúde pública, especialmente nas áreas de controle do tabagismo, alimentação saudável, controle do álcool e atividade física. Esse trabalho é realizado por meio de ações de advocacy, que incluem incidência política, comunicação, mobilização, formação de redes e pesquisa, entre outras. Conheça mais em https://actbr.org.br/Confira o papo entre o leigo curioso, Ken Fujioka, e o cientista PhD, Altay de Souza.>> OUÇA (57min 41s)*Naruhodo! é o podcast pra quem tem fome de aprender. Ciência, senso comum, curiosidades, desafios e muito mais. Com o leigo curioso, Ken Fujioka, e o cientista PhD, Altay de Souza.Edição: Reginaldo Cursino.http://naruhodo.b9.com.br*APOIO: ACTEste episódio é apresentado pelo Sebrae Rio. Sabe aquelas pessoas que a gente admira pela criatividade, pela capacidade de liderar projetos ou de transformar ideias em realidade? Você pode ser uma dessas pessoas com o apoio do Sebrae Rio, desenvolvendo habilidades com a educação empreendedora, que não é só pra quem quer abrir um negócio: essas habilidades são superimportantes pra qualquer profissional.E se você é gestor ou professor de uma instituição de ensino, você pode levar a Educação Empreendedora para os seus alunos.É de graça e ainda emite certificado!Saiba mais, acessando atitude.sebraerj.com.br. E compartilhe suas habilidades empreendedoras nas redes sociais com a hashtag #TáNaSuaAtitude.Sebrae Rio: empreender tá na sua atitude.*REFERÊNCIASRethink Vape: Development and evaluation of a risk communication campaign to prevent youth E-cigarette usehttps://www.sciencedirect.com/science/article/pii/S0306460320307942?casa_token=stt22CU9-6AAAAAA:YPkZZ53Ftu3nkkekilolsWuJNKUbryiRjeLSIDReCt7I_VzpUe7m00pMu7x8ekXPen_tBRSmplYImpact of messages about scientific uncertainty on risk perceptions and intentions to use electronic vaping productshttps://www.sciencedirect.com/science/article/pii/S0306460318312140?casa_token=cLYGPqH_5ycAAAAA:ENqaVvNiFavJdpveZm6twD9JcfZP-EziEL0Vzt9gTE6wY4TLGguWJSDbG0-qZvIyTnMnkIyh3oIComics and Morals: Communicating the Risks of Vaping to Young Adults Through Moralized Graphic Comicshttps://www.proquest.com/openview/30046a092e0b52154768a5774baf4607/1?pq-origsite=gscholar&cbl=18750&diss=yHealth Messaging Strategies for Vaping Prevention and Cessation Among Youth and Young Adults: A Systematic Reviewhttps://www.tandfonline.com/doi/full/10.1080/10410236.2024.2352284Nicotina é até seis vezes maior em quem fuma cigarro eletrônico do que 20 cigarros comuns por diahttps://jornal.usp.br/ciencias/nicotina-e-ate-seis-vezes-maior-em-quem-fuma-cigarro-eletronico-do-que-20-cigarros-comuns-por-dia/Vaping in Youthhttps://jamanetwork.com/journals/jama/article-abstract/2822166?casa_token=AOMeZZluas0AAAAA:sLpdsaUTGQ6B9626AzCUq92sKEiOiQb4ZukceE2Z_lWxzYOfJ69UkK2sLlCNLiN9ulGOk1OzkJE&casa_token=j41vokSLcaUAAAAA:N7nCcnNEPuRTSdhY5abaMDWnmHMatAyw265mnYE3YUj1DOzb8Bt_VVuVMuPLwDh-amcoVdJ6_J8Trends in long term vaping among adults in England, 2013-23: population based studyhttps://www.bmj.com/content/386/bmj-2023-079016.shortA Systematic Review of Predictors of Vaping Cessation Among Young Peophttps://academic.oup.com/ntr/advance-article/doi/10.1093/ntr/ntae181/7717604A Vaping Cessation Text Message Program for Adolescent E-Cigarette Usershttps://jamanetwork.com/journals/jama/article-abstract/2822082?casa_token=jFrwYbTuE00AAAAA:cjSPTgP0FeIYTFS13Uli6akYcN37xjahDcnuCGSEXrgJQMpxExcD2GExrwPO4gNPdb2HqQ9Nyqc&casa_token=TrYwGgae_xEAAAAA:XCLLhI4Ku1KjcxxJ1tIi74OJmwW2Y1eNjq60LVYbJ7B8M2TNh7GPdQwBQIBjDefqVwlkmcaW7TUSmoking and vaping alter genes related to mechanisms of SARS-CoV-2 susceptibility and severity: a systematic review and meta-analysishttps://publications.ersnet.org/content/erj/64/1/2400133.abstractThe Impact of Vaping on the Ocular Surface: A Systematic Review of the Literaturehttps://www.mdpi.com/2077-0383/13/9/2619Drug Use Frequency Variation and Mental Health During the COVID-19 Pandemic: an Online Surveyhttps://pmc.ncbi.nlm.nih.gov/articles/PMC8404543/Vaping among adults in England who have never regularly smoked: a population-based study, 2016–24https://www.thelancet.com/journals/lanpub/article/PIIS2468-2667(24)00183-X/fulltextAssociation of vaping with respiratory symptoms in U.S. young adults: Nicotine, cannabis, and dual vapinghttps://www.sciencedirect.com/science/article/pii/S009174352400330XTobacco Harm Reduction: The Industry's Latest Trojan Horse?https://exposetobacco.org/wp-content/uploads/tobacco-harm-reduction-cop10.pdfU.S. retail sales data show 86% of e-cigarette sales are for illegal productshttps://truthinitiative.org/research-resources/tobacco-industry-marketing/us-retail-sales-data-show-86-e-cigarette-sales-are?trk=feed_main-feed-card_feed-article-contentThe Normalization of Vaping on TikTok Using Computer Vision, Natural Language Processing, and Qualitative Thematic Analysis: Mixed Methods Studyhttps://www.jmir.org/2024/1/e55591/From Smoking to Vaping: The Motivation for E-Cigarette Use at the Neurobiological Level – An fMRI Studyhttps://academic.oup.com/ntr/advance-article/doi/10.1093/ntr/ntae273/7906109Vaping and Smoking Cue Reactivity in Young Adult Nonsmoking Electronic Cigarette Users: A Functional Neuroimaging Studyhttps://academic.oup.com/ntr/advance-article-abstract/doi/10.1093/ntr/ntae257/7863347Impact of Electronic Cigarettes on the Cardiovascular Systemhttps://pmc.ncbi.nlm.nih.gov/articles/PMC5634286/Naruhodo #207 - Vape e cigarro eletrônico são seguros? (2019)https://www.youtube.com/watch?v=Raa9CUrIFbsNaruhodo #85 - Por que é tão difícil parar de fumar?https://www.youtube.com/watch?v=SPkIT0ehoisNaruhodo #49 - O que causa o vício?https://www.youtube.com/watch?v=--Z_ylPXIWcNaruhodo #94 - O que é o Teorema de Bayes? (E o que horóscopo tem a ver com isso?)https://www.youtube.com/watch?v=BE5fpsfPerwNaruhodo #328 - Existem "gatilhos mentais"?https://www.youtube.com/watch?v=fxBQJlin8Z4Naruhodo #419 - Maconha faz mal? - Parte 1 de 2https://www.youtube.com/watch?v=cvLTh2bKPiQNaruhodo #420 - Maconha faz mal? - Parte 2 de 2https://www.youtube.com/watch?v=F7wVcGvpoGANaruhodo #267 - O que é dissonância cognitiva?https://www.youtube.com/watch?v=1xJwqmir5UwNaruhodo #268 - O que é dissonância cognitiva? - Parte 2 de 2https://www.youtube.com/watch?v=--OHlHmOQTM*APOIE O NARUHODO PELA PLATAFORMA ORELO!O podcast Naruhodo está no Orelo: bit.ly/naruhodo-no-oreloE é por meio dessa plataforma de apoio aos criadores de conteúdo que você ajuda o Naruhodo a se manter no ar.Você escolhe um valor de contribuição mensal e tem acesso a conteúdos exclusivos, conteúdos antecipados e vantagens especiais.Além disso, você pode ter acesso ao nosso grupo fechado no Telegram, e conversar comigo, com o Altay e com outros apoiadores.E não é só isso: toda vez que você ouvir ou fizer download de um episódio pelo Orelo, vai também estar pingando uns trocadinhos para o nosso projeto.Então, baixe agora mesmo o app Orelo no endereço Orelo.CC ou na sua loja de aplicativos e ajude a fortalecer o conhecimento científico.bit.ly/naruhodo-no-orelo
Vapes contain nicotine, which is toxic and addictive, as well as a range of other toxic chemicals. These toxins are presented with sweet smelling fruity flavours. So should people vape?
Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research interview Andrea Villanti. Associate Professor Jamie Hartmann-Boyce and Associate Professor Nicola Lindson discuss the new evidence in e-cigarette research and interview Associate Professor Andrea Villanti, Department of Health Behavior, Society, and Policy, Rutgers School of Public Health. Andrea Villanti's research focuses on young adult tobacco use including predictors and patterns of use and interventions to reduce tobacco use in young adults. Dr Villanti describes their randomised controlled trial to test the effect of three exposures to eight nicotine corrective messages on beliefs about nicotine, nicotine replacement therapy, e-cigarettes and reduced nicotine content cigarettes at 3-month follow-up. Their study concluded that repeated exposure to NCM was necessary to reduce false beliefs about nicotine and tobacco products and is reported in Tobacco Control e-publication, doi:10.1136/ tc-2023-058252. This podcast is a companion to the electronic cigarettes Cochrane living systematic review and shares the evidence from the monthly searches. Our literature searches carried out on 1st May found: One new study by Rabenstein A et al, Implications of Switching from Conventional to Electronic Cigarettes on Quality of Life and Smoking Behaviour: Results from the EQualLife Trial. European Addiction Research / 2024;(c60, 9502920):1-9 Three new ongoing studies: NCT06372899; NCT06373679 and Polosa et al, Protocol for the "magnitude of cigarette substitution after initiation of e-cigarettes and its impact on biomarkers of exposure and potential harm in dual users" (MAGNIFICAT) study, Frontiers in Public Health / 2024;12(101616579):1348389, DOI 10.3389/fpubh.2024.1348389 For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review updated in January 2024 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub8/full This podcast is supported by Cancer Research UK.
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-381 Overview: While the aerosol in e-cigarettes does contain toxicants and carcinogens, since it is not burned like combustible tobacco cigarettes, vaping exposes the user to fewer toxicants and chemicals. Many consider using e-cigarettes for smoking cessation, but evidence has been conflicting. Tune in as we discuss a recent review examining the efficacy of e-cigarettes in aiding smoking cessation and explore potential adverse effects associated with their usage. Episode resource links: Lin, H. X., Liu, Z., Hajek, P., Zhang, W. T., Wu, Y., Zhu, B. C., Liu, H. H., Xiang, Q., Zhang, Y., Li, S. B., Pesola, F., & Wang, Y. Y. (2024). Efficacy of Electronic Cigarettes vs Varenicline and Nicotine Chewing Gum as an Aid to Stop Smoking: A Randomized Clinical Trial. JAMA internal medicine, 10.1001/jamainternmed.2023.7846. Advance online publication. https://doi.org/10.1001/jamainternmed.2023.7846 Lindson, N., Butler, A. R., McRobbie, H., Bullen, C., Hajek, P., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., Livingstone-Banks, J., Morris, T., & Hartmann-Boyce, J. (2024). Electronic cigarettes for smoking cessation. The Cochrane database of systematic reviews, 1(1), CD010216. https://doi.org/10.1002/14651858.CD010216.pub8 Sanford BT, Brownstein NC, Baker NL, et al. Shift From Smoking Cigarettes to Vaping Nicotine in Young Adults. JAMA Intern Med. Published online November 13, 2023. doi:10.1001/jamainternmed.2023.5239 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
Credits: 0.25 AMA PRA Category 1 Credit™ CME/CE Information and Claim Credit: https://www.pri-med.com/online-education/podcast/frankly-speaking-cme-381 Overview: While the aerosol in e-cigarettes does contain toxicants and carcinogens, since it is not burned like combustible tobacco cigarettes, vaping exposes the user to fewer toxicants and chemicals. Many consider using e-cigarettes for smoking cessation, but evidence has been conflicting. Tune in as we discuss a recent review examining the efficacy of e-cigarettes in aiding smoking cessation and explore potential adverse effects associated with their usage. Episode resource links: Lin, H. X., Liu, Z., Hajek, P., Zhang, W. T., Wu, Y., Zhu, B. C., Liu, H. H., Xiang, Q., Zhang, Y., Li, S. B., Pesola, F., & Wang, Y. Y. (2024). Efficacy of Electronic Cigarettes vs Varenicline and Nicotine Chewing Gum as an Aid to Stop Smoking: A Randomized Clinical Trial. JAMA internal medicine, 10.1001/jamainternmed.2023.7846. Advance online publication. https://doi.org/10.1001/jamainternmed.2023.7846 Lindson, N., Butler, A. R., McRobbie, H., Bullen, C., Hajek, P., Begh, R., Theodoulou, A., Notley, C., Rigotti, N. A., Turner, T., Livingstone-Banks, J., Morris, T., & Hartmann-Boyce, J. (2024). Electronic cigarettes for smoking cessation. The Cochrane database of systematic reviews, 1(1), CD010216. https://doi.org/10.1002/14651858.CD010216.pub8 Sanford BT, Brownstein NC, Baker NL, et al. Shift From Smoking Cigarettes to Vaping Nicotine in Young Adults. JAMA Intern Med. Published online November 13, 2023. doi:10.1001/jamainternmed.2023.5239 Guest: Susan Feeney, DNP, FNP-BC, NP-C Music Credit: Richard Onorato
More than a decade after electronic cigarettes became broadly available in the United States, their merits are still being debated. Do these products help people quit smoking? How serious are the health risks associated with these products? In a two-part series, we hear from two researchers in tobacco control about their views. In part two, Stan Glantz, the Truth Initiative Distinguished Professor of Tobacco Control at the University of California San Francisco talks with Dr. Josh Sharfstein about his research into the harms of electronic cigarettes and the dangers of "dual use" of electronic cigarettes and traditional cigarettes. In an epilogue, Public Health On Call audio producer Matt Martin talks with Lindsay Smith Rogers about his personal history of tobacco use – including his efforts to quit with electronic cigarettes. Read Glantz's paper in New England Journal of Medicine Evidence: https://evidence.nejm.org/doi/full/10.1056/EVIDoa2300229 Listen to part one of the series here: https://johnshopkinssph.libsyn.com/755-electronic-cigarettes-part-1-do-e-cigs-help-people-quit-smoking
More than a decade after electronic cigarettes became broadly available in the United States, their merits are still being debated. Do these products help people quit smoking? How serious are the health risks associated with these products? In a two-part series, we hear from two researchers in tobacco control about their views. In part one, Dr. Nancy Rigotti, Professor of Medicine at Harvard Medical School talks with Dr. Josh Sharfstein about the use of e-cigarettes for smoking cessation. Read her editorial in the New England Journal of Medicine: https://www.nejm.org/doi/full/10.1056/NEJMe2314977
Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research interview Reto Auer, Bern University, Switzerland. Associate Professor Jamie Hartmann-Boyce and Dr Nicola Lindson discuss the new evidence in e-cigarette research and interview Professor Reto Auer, primary care physician and clinical researcher from the Institute of Primary Health Care (BIHAM), University of Bern. Reto Auer is Head of the Substance Use Unit, where he leads a variety of research projects, including a large randomized controlled trial designed to test the efficacy, safety and toxicology of nicotine e-cigarettes. Jamie Hartmann-Boyce interviews Reto Auer about his new study published in the New England Journal of Medicine ‘Electronic nicotine delivery systems for smoking cessation'. This trial randomized 1246 participants: 622 to free e-cigarettes and e-liquids, standard-of-care smoking-cessation counselling, and optional (not free) nicotine-replacement therapy; and 624 participants to a control group, which received standard counselling and a voucher, which they could use for any purpose, including nicotine-replacement therapy. This study was funded by the Swiss National Science Foundation and others and registered as ESTxENDS NCT03589989. The percentage of participants with validated continuous abstinence from tobacco smoking was 28.9% in the intervention group and 16.3% in the control group (relative risk, 1.77; 95% confidence interval, 1.43 to 2.20). The study concluded that adding e-cigarettes to standard smoking-cessation counselling resulted in greater abstinence from tobacco use among smokers than smoking-cessation counselling alone. DOI: 10.1056/NEJMoa2308815 This podcast is a companion to the electronic cigarettes Cochrane living systematic review and shares the evidence from the monthly searches. Our literature searches carried out on 1st February found the following 1 new study by Lin 2024 (Lin, H-X, Liu Z, Hajek P, Zhang W-T, Wu Y, Zhu B-C, Liu H-H, Xiang Q, Zhang Y, Li S-B, Pesola F, Wang Y-Y, Efficacy of Electronic Cigarettes vs Varenicline and Nicotine Chewing Gum as an Aid to Stop Smoking: A Randomized Clinical Trial, JAMA internal medicine / 2024;(101589534).) 3 new ongoing studies: NCT06169813, E-cigarette Harm Reduction Among PLWHA in South Africa. ISRCTN14068059, E-cigarettes for smoking cessation and reduction in people with a mental illness. Hameed A, Malik D, Clinical study protocol on electronic cigarettes and nicotine pouches for smoking cessation in Pakistan: a randomized controlled trial, Trials / 2024;25(1):9 3 papers linked to studies included in the review: Scheibein F, McGirr K, Morrison A, Roche W, Wells JSG, Correction to: an exploratory non-randomized study of a 3-month electronic nicotine delivery system (ENDS) intervention with people accessing a homeless supported temporary accommodation service (STA) in Ireland, Harm reduction journal 2021;18(1):113 Pesola F, Smith KM, Phillips-Waller A, Przulj D, Griffiths C, Walton R, McRobbie H, Coleman T, Lewis S, Whitemore R, Clark M, Ussher M, Sinclair L, Seager E, Cooper S, Bauld L, Naughton F, Sasieni P, Manyonda I, Hajek P, Safety of e-cigarettes and nicotine patches as stop-smoking aids in pregnancy: Secondary analysis of the Pregnancy Trial of E-cigarettes and Patches (PREP) randomized controlled trial, Addiction (Abingdon, England) / 2024 Trigg J, Rich J, Williams E, Gartner CE, Guillaumier A, Bonevski B, Perspectives on limiting tobacco access and supporting access to nicotine vaping products among clients of residential drug and alcohol treatment services in Australia, Tobacco control 2023 For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 Associate Professor Jamie Hartmann-Boyce and Dr Nicola Lindson discuss the new evidence in e-cigarette research and interview Professor Reto Auer, primary care physician and clinical researcher from the Institute of Primary Health Care (BIHAM), University of Bern. Reto Auer is Head of the Substance Use Unit, where he leads a variety of research projects, including a large randomized controlled trial designed to test the efficacy, safety and toxicology of nicotine e-cigarettes. Jamie Hartmann-Boyce interviews Reto Auer about his new study published in the New England Journal of Medicine ‘Electronic nicotine delivery systems for smoking cessation'. This trial randomized 1246 participants: 622 to free e-cigarettes and e-liquids, standard-of-care smoking-cessation counselling, and optional (not free) nicotine-replacement therapy; and 624 participants to a control group, which received standard counselling and a voucher, which they could use for any purpose, including nicotine-replacement therapy. This study was funded by the Swiss National Science Foundation and others and registered as ESTxENDS NCT03589989. The percentage of participants with validated continuous abstinence from tobacco smoking was 28.9% in the intervention group and 16.3% in the control group (relative risk, 1.77; 95% confidence interval, 1.43 to 2.20). The study concluded that adding e-cigarettes to standard smoking-cessation counselling resulted in greater abstinence from tobacco use among smokers than smoking-cessation counselling alone. DOI: 10.1056/NEJMoa2308815 This podcast is a companion to the electronic cigarettes Cochrane living systematic review and shares the evidence from the monthly searches. Our literature searches carried out on 1st February found the following 1 new study by Lin 2024 (Lin, H-X, Liu Z, Hajek P, Zhang W-T, Wu Y, Zhu B-C, Liu H-H, Xiang Q, Zhang Y, Li S-B, Pesola F, Wang Y-Y, Efficacy of Electronic Cigarettes vs Varenicline and Nicotine Chewing Gum as an Aid to Stop Smoking: A Randomized Clinical Trial, JAMA internal medicine / 2024;(101589534).) 3 new ongoing studies: NCT06169813, E-cigarette Harm Reduction Among PLWHA in South Africa. ISRCTN14068059, E-cigarettes for smoking cessation and reduction in people with a mental illness. Hameed A, Malik D, Clinical study protocol on electronic cigarettes and nicotine pouches for smoking cessation in Pakistan: a randomized controlled trial, Trials / 2024;25(1):9 3 papers linked to studies included in the review: Scheibein F, McGirr K, Morrison A, Roche W, Wells JSG, Correction to: an exploratory non-randomized study of a 3-month electronic nicotine delivery system (ENDS) intervention with people accessing a homeless supported temporary accommodation service (STA) in Ireland, Harm reduction journal 2021;18(1):113 Pesola F, Smith KM, Phillips-Waller A, Przulj D, Griffiths C, Walton R, McRobbie H, Coleman T, Lewis S, Whitemore R, Clark M, Ussher M, Sinclair L, Seager E, Cooper S, Bauld L, Naughton F, Sasieni P, Manyonda I, Hajek P, Safety of e-cigarettes and nicotine patches as stop-smoking aids in pregnancy: Secondary analysis of the Pregnancy Trial of E-cigarettes and Patches (PREP) randomized controlled trial, Addiction (Abingdon, England) / 2024 Trigg J, Rich J, Williams E, Gartner CE, Guillaumier A, Bonevski B, Perspectives on limiting tobacco access and supporting access to nicotine vaping products among clients of residential drug and alcohol treatment services in Australia, Tobacco control 2023 For further details see our webpage under 'Monthly search findings': https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 For more information on the full Cochrane review updated in January 2024 see: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD010216.pub8/full This podcast is supported by Cancer Research UK. This podcast is supported by Cancer Research UK.
Among the nearly 100 reviews produced by the Cochrane Tobacco Addiction Group, their review of the use of electronic cigarettes in smoking cessation is now being managed as a living systematic review, with monthly searches to keep an eye on the evidence base, so that the published review can be refreshed as necessary. The review was re-badged as a living review in 2021 and its fourth update in this format was published in January 2024. Here's one of the authors, Ailsa Butler from the University of Oxford in the UK to summarise the latest findings.
Among the nearly 100 reviews produced by the Cochrane Tobacco Addiction Group, their review of the use of electronic cigarettes in smoking cessation is now being managed as a living systematic review, with monthly searches to keep an eye on the evidence base, so that the published review can be refreshed as necessary. The review was re-badged as a living review in 2021 and its fourth update in this format was published in January 2024. Here's one of the authors, Ailsa Butler from the University of Oxford in the UK to summarise the latest findings.
Professor Emily Banks AM is a trailblazer in tobacco and e-cigarette research. Her world-leading review of the global evidence on the health effects of e-cigarettes has sparked national and international discussion. The use of e-cigarettes, or vaping, in Australia poses serious public health risks, especially among young people. In this episode, Professor Emily Banks discusses the Australian Government's new e-cigarette product legislation reform alongside the bigger picture of vaping practices in Australia and her review of the global evidence, Health Impacts of Electronic Cigarettes. "The latest evidence is four out of five teenagers would say it's easy to get hold of e-cigarettes or vapes and other people are saying, oh, well we should just educate kids about the dangers, but that's like someone being in a flood and saying, oh, by the way, don't get wet." Professor Emily Banks AM
Comprehensive coverage of the day's news with a focus on war and peace; social, environmental and economic justice. Unanimous County Commission votes restores Justin Pearson to Tennessee House seat after Republican expulsion The Biden Administration proposes strict new emission standards aimed at accelerating adoption of electric vehicles California State Senate debates bill to force state public employee and teacher pension funds to divest from fossil fuels Shocking Ukrainian video shows Russians purportedly beheading a Ukrainian soldier The post Expelled Tennessee Black lawmaker regains his post; Biden Administration proposes ambitious new rules on electric vehicles; Juul to pay nearly $500 million for marketing electronic cigarettes to youth: The Pacifica Evening News, Weekdays – April 12, 2023 appeared first on KPFA.
Comprehensive coverage of the day's news with a focus on war and peace; social, environmental and economic justice. Unanimous County Commission votes restores Justin Pearson to Tennessee House seat after Republican expulsion The Biden Administration proposes strict new emission standards aimed at accelerating adoption of electric vehicles California State Senate debates bill to force state public employee and teacher pension funds to divest from fossil fuels Shocking Ukrainian video shows Russians purportedly beheading a Ukrainian soldier The post Expelled Tennessee Black lawmaker regains his post; Biden Administration proposes ambitious new rules on electric vehicles; Juul to pay nearly $500 million for marketing electronic cigarettes to youth: The Pacifica Evening News, Weekdays – April 12, 2023 appeared first on KPFA.
Are e-cigarettes effective in helping smokers to quit? It's one of the most hotly contested questions in the battle over vaping, but an answer may finally be in hand. According to the latest Cochrane Review of Electronic Cigarettes for Smoking Cessation, there is “high-certainty evidence” that nicotine vapes are more effective than traditional nicotine replacement therapies, such as nicotine patches and gum, in helping people to quit smoking. Dr. Jamie Hartmann-Boyce, associate professor at the University of Oxford's Nuffield Department of Primary Care Health Sciences and editor at Cochrane Tobacco Review Group, is joining us today to discuss the new evidence. Only on RegWatch by RegulatorWatch.com. Released: November 23, 2022 Produced by Brent Stafford https://youtu.be/U0ytawxQgWs Make RegWatch happen, go to https://support.regulatorwatch.com
Listen to the new "Unsung Stewards" podcast from The Rippel Foundation's ReThink Health Initiative.Health Affairs' Ellen Bayer and Kathleen Haddad break down the under-discussed state ballot initiatives that focused on health care in the 2022 mid-term elections.Related Links: What The 2022 Midterm Results Might Mean for Health Care (Health Affairs Forefront) What Recent State Elections Mean for Health Care (Health Affairs Forefront) A Proposed Policy Agenda for Electronic Cigarettes in the US: Product, Price, Place, and Promotion (Health Affairs) The FDA Stands By as the Vaping Industry Flout Its Orders (Stat News) Currently, more than 70 percent of our content is freely available — and we'd like to keep it that way. With your support, we can continue to keep our digital publication Forefront and podcasts free for everyone.Subscribe: RSS | Apple Podcasts | Spotify | Castro | Stitcher | Deezer | Overcast
Associate Professor Jamie Hartmann-Boyce and Dr Nicola Lindson discuss the emerging evidence in e-cigarette research and interview Dr Leonie Brose, King's College London. This podcast is a companion to the electronic cigarettes Cochrane living systematic review and shares the evidence from the monthly searches. In the October episode Jamie Hartmann-Boyce interviews Dr Leonie Brose, Reader in Addiction Education and Nicotine Research at King's College London. Leonie Brose talks about the findings of a randomised controlled trial carried out with Dr Markos Klonizakis and the team at Sheffield Hallam University on the medium- and longer-term cardiovascular effects of e-cigarettes in adults making a stop-smoking attempt. The study compared cardiovascular effects in smokers attempting to quit smoking using e-cigarettes with or without nicotine or prescription nicotine replacement therapy (NRT). The study concluded that smokers attempting to quit experienced positive cardiovascular impact after both a 3- and 6-month period. None of the groups (i.e., nicotine-containing and nicotine-free e-cigarettes or NRT) offered superior cardiovascular benefits to the others. https://doi.org/10.1186/s12916-022-02451-9 Dr Brose also discusses the findings of the report by the Office for Health Improvements and Disparities (OHID) on Nicotine vaping in England: 2022 evidence update summary. The report aims to summarise the evidence on vaping products and to inform policies and regulations. It is a large body of work with 16 chapters covering policy and regulation, vaping and youth and presents the evidence on biomarkers of exposure and biomarkers associated with cancer, respiratory, cardiovascular and other health outcomes. The report also has chapters on fires, poisons and explosions linked to ECs, heated tobacco products and perceptions of harm. The headline from the report was that vaping poses only a small fraction of the risk of smoking combustible cigarettes. Jamie and Nicola also bring us up to date with the literature search conducted in October 2022. The October search identified 1 new study (https://doi.org/10.1186/s12916-022-02451-9), 3 ongoing studies and 1 record linked to a previously identified study. We will include the studies we have found in future updates of the Cochrane review. OHID Report: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1107701/Nicotine-vaping-in-England-2022-report.pdf https://www.gov.uk/government/publications/nicotine-vaping-in-england-2022-evidence-update/nicotine-vaping-in-england-2022-evidence-update-summary For more information on the full Cochrane review updated in September 2021 see: https://doi.org/10.1002/14651858.CD010216.pub6 or our webpage https://www.cebm.ox.ac.uk/research/electronic-cigarettes-for-smoking-cessation-cochrane-living-systematic-review-1 This podcast is supported by Cancer Research UK.
Ryan Wiggins chats with Fox News Contributor, Deroy Murdock. Murdock discusses the J-6 hearings, the ban of “Juul” electronic cigarettes, and an update on the Southern Border.
Federal health officials on Thursday ordered Juul to pull its electronic cigarettes from the U.S. market, the latest blow to the embattled company widely blamed for sparking a national surge in teen vaping. man is in custody after attacking a family member with a mailbox flag. See omnystudio.com/listener for privacy information.
Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Professor Billie Bonevski. In this episode Assistant Professor Jamie Hartmann-Boyce and Dr Nicola Lindson discuss the emerging evidence in e-cigarette research and interview Professor Billie Bonevski. This podcast is a companion to the electronic cigarettes Cochrane living systematic review and shares the evidence from the monthly searches. In the February episode Dr Nicola Lindson talks with Professor Billie Bonevski, Professor of Public Health, Flinders University, South Australia. Professor Billie Bonevski discusses her Team's QuiENDS pilot trial of electronic cigarettes for smoking cessation among people in alcohol and other drug treatment. Professor Bonevski discusses e-cigarettes as a harm reduction tool and as part of a solution to high levels of smoking and very low or non-existent rates of quitting seen in this group. The study looks at people using e-cigarettes to quit abruptly or to reducing more gradually. Going forward work has started on the follow up Harmony Trial. Jamie and Nicola also bring us up to date with the literature search conducted on February 1st 2022. The February search found 2 ongoing studies and 2 records linked to a studies already included the review. We will include the studies we have found in future updates of the Cochrane review.
Jamie Hartmann-Boyce and Nicola Lindson discuss emerging evidence in e-cigarette research and interview Professor Billie Bonevski. In this episode Assistant Professor Jamie Hartmann-Boyce and Dr Nicola Lindson discuss the emerging evidence in e-cigarette research and interview Professor Billie Bonevski. This podcast is a companion to the electronic cigarettes Cochrane living systematic review and shares the evidence from the monthly searches. In the February episode Dr Nicola Lindson talks with Professor Billie Bonevski, Professor of Public Health, Flinders University, South Australia. Professor Billie Bonevski discusses her Team's QuiENDS pilot trial of electronic cigarettes for smoking cessation among people in alcohol and other drug treatment. Professor Bonevski discusses e-cigarettes as a harm reduction tool and as part of a solution to high levels of smoking and very low or non-existent rates of quitting seen in this group. The study looks at people using e-cigarettes to quit abruptly or to reducing more gradually. Going forward work has started on the follow up Harmony Trial. Jamie and Nicola also bring us up to date with the literature search conducted on February 1st 2022. The February search found 2 ongoing studies and 2 records linked to a studies already included the review. We will include the studies we have found in future updates of the Cochrane review.
In this Roots of Reality Experiences episode, historian Ben Baumann talks with Dr. Page Dobbs about the differences between traditional cigarettes and e-cigarettes, the health issues associated with e-cigarettes, and the disturbing tactics used by e-cigarette companies to market their products. (Dr. Page Dobbs earned a MS and a PhD in Community Health Promotion from the University of Arkansas' College of Education and Health Professions. She joined the University of Arkansas faculty as an Assistant Professor of Public Health in the Department of Health, Human Performance and Recreation, in 2020. Dr. Dobbs' research focuses on social factors that influence perceptions and behaviors among vulnerable populations. She has published quantitative, qualitative, and mixed-methods research that examined the use of cigarettes and electronic cigarettes (e-cigarettes) among youth, young adults, minority populations, and pregnant women. She has also developed and validated theory-based measures that examined young adults' behavioral intention to use e-cigarettes.) ResearchGate- researchgate.net/profile/Page-Dobbs (The memories, comments, and viewpoints shared by guests in the interviews do not represent the viewpoints of, or speak for Roots of Reality)
Jamie Hartmann-Boyce and Nicola Lindson discuss the September 2021 update of their Cochrane living review of electronic cigarettes for smoking cessation, their response to a paper by Pisinger et al 2020 and emerging evidence in e-cigarette research. In this episode Jamie Hartmann-Boyce and Nicola Lindson discuss the emerging evidence in e-cigarette research and two recent publications by the group: the September 2021 update to the Cochrane living review of electronic cigarettes for smoking cessation; and a response to a paper by Pisinger et al 2020. This podcast is a companion to our Cochrane living systematic Review and shares the evidence from monthly searches and review findings. Jamie and Nicola discuss the team's response to a paper by Pisinger and Vestbo 2020, and underline that the aim of the Cochrane process is to always focus on the evidence (DOI: 10.1183/13993003.02117-2021 or link). They then outline the findings of the September update to the review which includes five new studies that have been added since the April 2021 version and includes search findings up to 1st May 2021. Overall the review includes 61 studies representing 16,759 participants. The main findings remain the same and some new comparisons have been included. There is still moderate certainty that nicotine containing e-cigarettes help more people to quit at 6 months or longer compared to e-cigarettes without nicotine or than NRT (nicotine replacement therapy). Uncertainty also still exists around nicotine containing e-cigarettes compared to no intervention (e.g. continued smoking). This reflects that the quality of the evidence is considered very low according to Cochrane standards. There is moderate certainty evidence that neither nicotine e-cigarettes nor non-nicotine e-cigarettes result in higher numbers of adverse or serious adverse effects. Turning to new comparisons this update includes a study of a pod device (Russell et al), the findings were consistent with the other included studies that showed that more people quit at 6 months or longer using EC than with NRT. This update also includes a study comparing nicotine salt to free-base nicotine e-cigarettes; no clear differences were found between the two. We also included studies that provided 'dual users' (people who already use EC and tobacco cigarettes) with advice on how to use their EC to quit smoking; in one study there was no usable data in a second larger study (Martinez) there was a marginally better quit rate, however there was no clear evidence of benefit. In response to feedback, for the first time in this update, data is included on the proportion of participants still using e-cigarettes or quitting aids) at six months or longer. Data from two studies comparing nicotine EC with NRT were notably different, with one finding no difference in the proportion of participants still using study product at longest follow-up, and the other finding significantly higher levels of EC use than NRT. There was no evidence for a difference in the proportion of people still using EC at longest follow-up in two studies comparing nicotine EC with non-nicotine EC. For all other studies the majority of participants that had been given nicotine EC at the start of the study were still using EC at 6 months or longer. Jamie and Nicola discuss the different ways that this result could be interpreted. It will be important to collect more information on this outcome. For more information on the September Cochrane review see: https://doi.org/10.1002/14651858.CD010216.pub6 or our webpage. Jamie and Nicola also bring us up to date with the literature search conducted on August 1st and September 1st. The August search found one linked study by Rubenstein et al 2021 (doi: 10.1016/j.addbeh.2021.107037) and two new ongoing studies (El-Khoury et al 2021 (doi: 10.1136/bmjopen-2021-048859); and NCT04708106 2021). No new studies were found in the September 1st search. We will include the studies we've found in future updates of the Cochrane review.
This month on Episode 28 of Discover CircRes, host Cynthia St. Hilaire highlights four original research articles featured in the August 20th and September 3rd issues of Circulation Research. This episode also features an in-depth conversation with Dr Scott Cameron from the Cleveland Clinic and Dr Milka Koupenova from the University of Massachusetts Medical Center about their study, SARS-CoV-2 Initiates Programmed Cell Death in Platelets. Article highlights: Gupta, et al. Electronic Cigarettes and Oxidized Lipids Bartosova, et al. Glucose Derivative Induced Vasculopathy in CKD Atmanli, et al. DMD Correction Attenuates Cardiac Abnormalities Ma, et al. Length Dependent Activation in Porcine Myocardium Cindy St. Hilaire: Hi, and welcome to Discover CircRes, the podcast for the American Heart Association's journal, Circulation Research. I'm your host, Dr Cindy St. Hilaire from the Vascular Medicine Institute at the University of Pittsburgh, and today I will be highlighting articles presented in our August 20th and September 3rd issues of Circulation Research. I also will speak with Dr Scott Cameron from the Cleveland Clinic and Dr Milka Koupenova from the University of Massachusetts Medical Center about their study, SARS-CoV-2 Initiates Programmed Cell Death in Platelets. Cindy St. Hilaire: The first article I want to share is titled Electronic and Tobacco Cigarettes Alter Polyunsaturated Fatty Acids and Oxidative Biomarkers. The first author is Rajat Gupta and the corresponding author is Jesus Araujo from UCLA. E-cigarettes have surged in popularity in the last decade and while many people switching from traditional cigarettes to smokeless ones view the latter as a safe alternative to smoking tobacco, emerging data shows that E-cigarettes cause adverse effects such as oxidative stress, inflammation and endothelial dysfunction in users. The aerosols produced during vaping contain similar levels of reactive oxygen species, also called ROS, as the vapors of tobacco smoke. However, data on the extent to which E-cigarettes, E-cigarette ROS, influences cardiovascular health is lacking. Cindy St. Hilaire: To address this, this group recruited 32 chronic users of E-cigarettes, 29 chronic tobacco smokers, and 45 individuals that used neither and they measured their plasma levels of oxidative biomarkers. The team found both similarities and differences between the E-cigarettes and the tobacco users. For example, both smoking groups had increased plasma antioxidant capacity and decreased levels of oxidized linoleic acid compared with the levels seen in non-users, while arachidonic acid levels were raised in tobacco smokers and reduced in E-cigarette users. Overall, however, the biomarker levels were deemed to be intermediate for E-cigarette users between the non-users and the tobacco users. This study suggests that while E-cigarettes carry a lower health risk than tobacco, they are by no means safe. Cindy St. Hilaire: The second article I want to share is titled Glucose Derivative Induced Vasculopathy in Children on Chronic Peritoneal Dialysis. The first author is Maria Bartosova and the corresponding author is Claus Schmitt and they're from the University of Heidelberg. Diabetes, high blood pressure and obesity are risk factors for both cardiovascular disease and chronic kidney disease. Worse still, loss of kidney function and even dialysis itself are thought to exacerbate cardiovascular issues. In the case of dialysis, it's thought that high levels of glucose degradation products, or GDPs, in the dialysis fluids can promote the addition of sugar moieties to vascular proteins and lipids causing vascular damage. To investigate this theory, Bartosova and colleagues studied vascular tissue from children with chronic kidney disease receiving dialysis fluids with either high levels or low levels of glucose degradation products and compared these to tissues from children not on dialysis at all. Cindy St. Hilaire: Proteome and transcriptome analysis of the vessel tissues revealed that compared with patients or no to low GDP fluids, patients receiving high GDP fluids had higher levels of damaging glycation, increased transcription of genes involved in cell death, and decreased transcription of genes involved in cell survival and cytoskeletal reorganization. In line with these findings, vessels from high GDP patients displayed considerable evidence of damage, such as markers of apoptosis, skeletal disintegration and thickened intimas. The results confirmed GDPs can cause vasculopathy and suggest low GDP fluids should be used for dialysis patients. Cindy St. Hilaire: The next article I want to share is titled Cardiac Myoediting Attenuates Cardiac Abnormalities in Human and Mouse Models of Duchenne Muscular Dystrophy. The first author is Ayhan Atmanli and the corresponding author is Eric Olson from UT Southwestern. Duchenne Muscular Dystrophy, or DMD, affects one in 5,000 baby boys and is caused by mutations in gene for dystrophin, an architectural protein essential for muscle cell integrity. Patients display profound muscle degeneration and weakness, with respiratory and heart muscle dysfunction being a major cause for death. With the recent improvements in respiratory medicine that extend the lives of patients, this group now focused on heart dysfunction and specifically, whether gene editing could mitigate it. The team created induced pluripotent stem cells, or iPSCs, from Duchenne Muscular Dystrophy patient and his healthy brother and showed that gene editing from the DMD cells enabled their development into normal-looking cardiomyocytes with normal contractile function and calcium handling, equivalent to that seen in healthy control cells. The unedited DMD cells, by contrast, did not develop normally. For great clinical relevance, the team edited DMD cells after cardiomyocyte differentiation showing that this reduced their propensity for arrhythmia, compared with that of unedited cells. Cindy St. Hilaire: Lastly, the team provided evidence to suggest gene editing may improve heart abnormalities in mice with the same mutation. All together the results are proof of principle and support of the development of gene editing therapy as treatment for DMD. Cindy St. Hilaire: The last article I want to share is titled The Super-Relaxed State and Length Dependent Activation in Porcine Myocardium. The first authors are Weikang Ma and Marcus Henze and the corresponding author is Thomas Irving and they're from the Illinois Institute of Technology. Myofilament length-dependent activation or LDA is the fundamental mechanism coupling the force of the heart's contraction to it's proceeding diastolic volume. In other words, LDA ensures that the more the heart fills, the stronger it contracts. Studies of rodent hearts have given insights into LDA mechanics. However, how it operates in large mammalian hearts is unknown. Using structural and biochemical analysis of pig myocardial fibers, this group found that compared with small stretches of the fibers which were equivalent to small diastolic volumes, long stretches induced greater ATP turnover and greater numbers of cross bridges between myosin and actin filaments which are critical contractile machinery proteins. Cindy St. Hilaire: Myosin motors can be found in three stages, engaged with actin, unengaged in a disordered, relaxed state but ready to engage, or super-relaxed state where they are essentially switched off. The team showed that as muscle stretch increased, the amount of super-relaxed myosin motors diminished with more myosin motors becoming engaged to enable a stronger contraction. When the fibers were treated with a myosin motor inhibitor, these stretch effects were impaired. In revealing the mechanisms of myofilament length-dependent activation, this study provides a platform for studying cardiomyopathies in which this system goes awry. Cindy St. Hilaire: So today, Dr Scott Cameron from the Cleveland Clinic and corresponding author of the paper, Dr Milka Koupenova from the University of Massachusetts Medical Center, are both with me to discuss their study, SARS-CoV-2 Initiates Programmed Cell Death in Platelets. And this article is in our September 3rd issue of Circ Research and for full disclosure, the editor of Circ Res, Dr Jane Freedman is also an author on this manuscript. And for full double disclosure, I know Dr Koupenova quite well as we were both graduate students together back in the Ravid Lab at Boston University. However, the full Editorial Board selects these articles, not just me alone and this one is timely, novel, and an amazing story. So thank you both for joining me today. Milka Koupenova: Thank you for having us. Scott Cameron: Privileged to be here. Cindy St. Hilaire: So before we jump into the story that is your paper, can you give us a little bit of background about platelets? I know for years, I guess certainly before Katya's lab, I just thought of platelets as little nucleus-free particles that clot. But we know they are so much more than that. So why are they so important? And how do they function to do more than just stop a bleed? Milka Koupenova: So this is a great question, Cindy, and I am happy that you alluded exactly to the anucleated nature of platelets. So platelets are cell fragments. They're precursors in the bone marrow, the megakaryocyte. They are the second most abundant blood component after the red blood cells. And traditionally, platelets have been known, as what you pointed out, as these little units that change their conformation once there is some form of a problem with either the vascular, which we have a cut, they come together, they form this clot, and bleeding is prevented. But as we have learned perhaps in the past 20 years that platelets have a profound immune role during various immune processes and infections for different kind of microbes. And particularly relevant to this paper is that we understand that platelets have clearly a role responding to the viruses and activating the immune system. Cindy St. Hilaire: Yeah, and that was actually my next question. You and Jane are the world-leading experts on platelets and viral responses. So what was known about that interaction, I guess before we started looking at SARS-CoV-2, what was known about that platelet virus or even type of virus interaction? Milka Koupenova: So SARS-CoV-2 is a RNA virus--respiratory virus that we actually thought similarly to influenza that it mostly stays in the lower respiratory tract where it becomes problematic. However, from our work with influenza, when we saw that in certain patients you actually can detect the virus in platelet. In the beginning of the pandemic, we hypothesized that perhaps, in some people, the virus crosses over into the circulation. And based on our previous studies with influenza, we wanted to see if that indeed is the case. Hence we initiated a study here at UMass with the department head who is also on the paper, Dr Finberg, who is a leading expert in influenza and novel virus and we collected platelets from people to see if we can detect it. And so in the beginning, we were not able to detect SARS-CoV-2 in platelets. So we collected platelets from 17 patients and by qPCR with the primers that the CDC has, for whatever reason I couldn't detect anything. And I was really frustrated because previous reports have shown that about 25%, in some people even 35% of the study population, SARS can be detected. So very interesting observations. Milka Koupenova: I could see it by immunofluorescence but I couldn't detect the RNA. And the story goes, that I attended a seminar on SARS-CoV-2 and the person was actually referencing a company that started from University of Pitt where you are. Cindy St. Hilaire: Oh, very nice. Milka Koupenova: And they do specific, it's called amplicon ARTIC v3 sequencing so they enrich for the SARS-CoV-2 RNA and screen by sequencing. And when we did that, we were able to detect it in all patients. So I freaked out and I said, "Oh my gosh, something is wrong." Milka Koupenova: And so I sent plasma, and I sent controls, and actually RNA from the virus and you can see beautifully that it's only in platelets. Four of the 17 people actually had RNA in the plasma, but what you can observe in all these people is that the virus is fragmented, meaning it's not infectious. And in a way what this tells us, it suggests that platelets are super important in the removing it from the circulation and they probably serve as a dead-end for the virus because you cannot find virus coming out of platelets and the RNA is chopped off. So what I would say, is that platelets are these amazing little units that serve as removal of the viral RNA for these particular viruses, respiratory viruses that are RNA viruses. Cindy St. Hilaire: I think that is so interesting. So essentially, they're almost like little composters that are chewing it up and preventing it from spreading in the organism. Milka Koupenova: Yes, and as a result there is a response. Cindy St. Hilaire: Scott, probably the most common thing that people know with SARS is that loss of smell, or taste, and things like that, but really that doesn't send anybody to the hospital. So really what are the symptoms of COVID-19 patients that tie in with platelets specifically? I feel like that's a lot of things that we maybe in the public, or on Twitter, and things didn't hear as much about. So really what are those big symptoms linking COVID and platelets and what are the implications of platelet death in the pathogenesis of COVID? Scott Cameron: So certainly I think several investigators are in the world of now showing that platelets are hyperactivated, Robbie Campbell and Matt Rondina put a really nice paper in Blood last year showing that platelets are hyperactive and there are other investigators who found something similar. And so the question is, what are the symptoms of hyperactive platelets in the SARS-CoV-2 patient? So what most of them would find is shortness of breath or dyspnea, and when they present to the emergency department, and certainly we saw this, the oxygen saturation which should be in the mid to high 90s on room air on an average person, was quite often low. It was in the 80s or 70s, sometimes even the 60s. Scott Cameron: And the real surprising thing was those are patients that would normally immediately be on a ventilator, but yet they could still be talking to you. And so if you have a platelet that's activated in a hyperthrombotic condition, like SARS-CoV-2, COVID-19, and then that forms a blood clot, you have a situation where the amount of oxygen the patients taking in and the amount of oxygen you're measuring in the artery is quite discrepant and we call that the alveolar arterial or oxygen gradient. So if you've got lots of platelet plugs through the microvasculature, it's going to take up some space the oxygen should be using for diffusing in. And so that would be manifested as shortness of breath and that's certainly one of the biggest tip-offs that a patient might have a blood clot, particularly in the lung. Cindy St. Hilaire: Some of these symptoms of COVID-19 are really worse in patients with comorbidities, diabetes, obesity and heart failure. Are platelets central to kind of the pathogenesis of those disease or the symptoms of those diseases? I guess the root of my question is, why do the comorbidities of diabetes, obesity, and heart failure make COVID worse? Is it something about those disease states themselves or is there a role for platelet? Scott Cameron: That's a brilliant question, no one's ever asked that before. And as Dr Koupenova said, I'm a little bit biased too because I firmly believe that in different disease states, the disease educates the platelets so you've got a different platelets phenotype. So focusing on diabetes, we know the platelet phenotype is different in diabetic patients. We know that platelet reactivity seems to be higher through the P2Y12 receptor. In terms of obesity, it is true, we know that, and this has been published also, and we know that the platelet phenotype is hyperactive in a patient with obesity and so that tells me that, that's a comorbidity that might affect platelet function and also vice versa for that case. And then in terms of why is it affecting males more prominently and more severely than females, well one of the beefs, I guess, that I had is that we treat diseases in women the same as we do in men assuming that the platelet phenotype in disease must be the same, but that's absolutely not true. And that's actually a theme that we have in our lab right now, we know that the behavior of platelets, and how platelets are educated in diseases is not all the same in women as in men and I think it's a huge disservice that we really had to have a pandemic that would make that quite clear to us. Cindy St. Hilaire: You kind of hit onto something that's really, I think it's now becoming more recognized certainly in the cardiovascular field and that is so many studies are really only on male mice, or only younger or older men, and we are missing not only a huge patient population, but probably some really interesting biology that is distinct. Milka Koupenova: So expanding on that, we know that in platelets, the toll-like receptors, and we've looked at the expression of all 10 in a study that we published in ATVB in 2015, actually, significantly if you look at Farmingham Heart Study data and the expression of these toll-like receptors they are increased in women versus men. And also, an interesting observation that never got published, once upon a time when I was doing studies with TLR7 mice is that if you inject TLR7 agonists, male mice would have a higher level of reduced platelet count than female mice at the same time points, right? And at that time it wasn't published. Definitely there are differences, but I also want to extrapolate a little bit on what was said at the beginning. We have to understand that when it comes to these comorbidities, everything affects a unit that doesn't have a nucleus, right? And diabetes and obesity have the so called profound, chronic inflammation of cytokines, such as IL6, that keep circulating. These things have effect on platelets. So we have two responses, we have the environment that affects platelets and we have the direct response of the virus that affects platelets. And that cumulative response truly can exhaust them and once they become exhausted, once they release their contents, as we show in this paper, then you're compromising their function and you will be compromising taking out the virus from one side and from the other side you're going to be compromising the environment because all of the content that comes out from a unit that already has free form proteins, it exhibits a true insult on what's being surrounded. So these clots that form in the lung or the platelets that circulate they no longer can be resolved properly. Cindy St. Hilaire: Yeah. Milka Koupenova: It's a balance. Cindy St. Hilaire: Yeah, so really it's like destroying the platelet not only are you destroying the vacuum that has to suck up those particles, you're then just dumping a whole bunch of pro-inflammatory things on all of the endothelial cell vasculature that those platelets are nearby. Cindy St. Hilaire: Actually that was one thing that I thought you spent a decent portion of the discussion on, and that is the method by which the blood is collected really impacts the outputs you observe in quote unquote platelets. Can you talk about the importance of that because I think that's one thing, certainly as a PhD who's just like, "Oh, yeah. I'm just going to collect blood from my mice and do this thing," how critical is that point in the experiment, in the blood collection? Milka Koupenova: So I am very adamant when it comes to platelets for the blood to be drawn in citrate. And I have to say that a lot of the studies that you would see in the literature are done using EDTA blood or serum. They all have their importance. I'm not going to dismiss it, but if you want to truly measure what's inside in plasma, versus what's inside in platelets, or what's inside in any cell for that matter, you got to go for citrate. You have to be very careful not to shake the blood. You have to be very careful not to cool down the blood. So the nurses probably hated me because often I would be like, "You can't do this. You can't put it on ice. You can't warm it up to above certain degrees. Everything has to be controlled and done correctly." Milka Koupenova: And so I had done in the past studies in which I would take plasma from the same patient in EDTA, in citrate and then isolate the RNA, have my tech isolate the RNA, and we send it to a fragment analyzer, and you can see how much more RNA you will get in the EDTA plasma. I'm not even talking about serum. Milka Koupenova: Serum is a very different thing, then you're definitely going to get platelet content in it, in the serum, right? So it's important to distinguish that perhaps when you're getting EDTA plasma you are looking at a content that could have been inside in platelet and I can't stress enough that when it comes to these particular studies, citrate, dextrose, phosphate is your place to go and be. Cindy St. Hilaire: So in terms of translational potential, what do your findings suggest about future therapies or targets to investigate as therapy? And is modulating platelets a potential for combating viral infections or mitigating their severity? Milka Koupenova: Well, Scott and I actually talk a lot about that. Scott Cameron: That's right. Milka Koupenova: I personally would say, control the inflammation, never let it go to platelet. Let me back up a little bit, if you have to, you have to, right? But your go to method should be inflammation, if you don't get to the point that you need to control platelets then you're in a better place because it becomes very fickle. From everything that you hear me say, you push it to one side and the balance is destroyed. You deactivate platelets or inhibit platelets well, are they now not able to pick up the virus and then you're now having the virus circulating somewhere. Now, if you don't treat platelets that's also not good. So you're in the very fickle situation if you get to the point that you need to control the activation of platelets and there are trials currently that are trying to look at those things. Scott, I'm going to refer this a little bit more to you because you have done some interesting things with that particular point. Scott Cameron: No, it's a great question, Milka, and I think that as platelet biologists, nobody more than I wanted it to be true that platelets would be the ultimate target. I mean, clearly patients with SARS-CoV-2 have thrombosis, clearly platelets are activated, so should we inactivate them? That was the whole point of the RECOVERY trial and one of the benefits I'll tell you before I sort of go into that is, working in a large organization like the Cleveland Clinic and we have access to data and lots of it extremely quickly, and so because of that I of course could see how many patients were coming into our hospital with thrombotic events. And I could see what the independent predictors of thrombotic events was and it wasn't the platelet count, sometimes platelet count was low, sometimes it's high in the SARS-CoV-2 patient. And if you took those individuals that were on aspirin, comparing them to those that are not in a propensity match study, one of the things that we find is that aspirin doesn't seem to affect or improve mortality or the number of blood clots in the patient with SARS-CoV-2. Scott Cameron: We compared that to all non-steroidal anti-inflammatory medications that patients may have been taking also in a propensity match study just in case it was the mechanism action of the drug, rather than the drug itself, and we found that NSAIDs not only did not protect patients, but they were not necessarily harmful either, which was one of the things that came out at the start of the pandemic. Among, I'll add, the absence of evidence based medicine and a lot of cases where naturally people, including clinicians, were scared and so they were going off label and they were trying a lot of different medications with really not a shred of randomized controlled data. Scott Cameron: But now that we're 18 months into it, the first and biggest study that came back was the RECOVERY trial, which we were all waiting on, where patients were given aspirin and short term mortality was examined over an observational period of one month. And just like we found in a propensity match study, which is as close as you'll get to a clinical trial in a retrospective manner, the prospect of RECOVERY trial actually showed the curves were almost super imposeable, those that got aspirin versus those that didn't. So I think low dose aspirin clearly is not going to be enough for those patients, but I'll also add that over the observational period of one month they also didn't see a higher incidence of death in those patients. And I think Milka's point is really well taken that you have to remember that as well being an entity of thrombosis, platelets are immunological entities and so you've got to really consider should we be inhibiting them and if you are inhibiting them, I think the time point at which you should inhibit them is what we should examine, not just an all or nothing, inhibited or not. Milka Koupenova: It's just in our linear brains we prefer to think of it as one straight, linear pathway, but it isn't, and I think platelets are actually a great example of how many pathways are feeding into one tiny fragment and that particular blood cell is inducing this profound response during these infections. Cindy St. Hilaire: I think most people have heard that angiotensin-converting enzyme 2, also called ACE2 is the receptor of SARS-CoV-2. The virus itself uses it to bind and become internalized into the cell, but there's been some discussion or even some discrepancy of data as to whether platelets truly express ACE2 and if that is the means for the virus to enter the platelets. So can you share with us what is the current state of knowledge about that? Scott Cameron: Yeah, just as a segue of some of the things that Milka said, I think the preparation of your sample is part of the answer. If you draw in the incorrect tube, if you the tube is not completely filled, and the ratio of citrates to whole blood isn't correct you're going to have discrepant results. If you biomechanically activate the platelets by drawing through a short needle, in a small-bore needle for example, that's going to activate the platelets. If you cool them, it's going to activate them. But then also, depending on how you decide to separate them, we always washed platelets in my lab, we wash them two or sometimes three times, and I can tell you if you use flow cytometer we get one white blood cell for every 12,000 platelets. Scott Cameron: And some investigators might go one step further and they'll a CD45 depletion set, which is certainly important if you're studying RNA. But one of the issues, as you well know, a CD45 is also on the surface of platelets, so if you start with a low expressing protein and you CD45 deplete them, you are actually going to get a decrease in your platelet yields. I've seen it, I think Milka's seen it, various other investigators have, and you might find yourself at the threshold of what your antibody can detect. It's also variably expressed. If you look at even healthy individuals, some of them have almost none. So if you look at 10 individuals, you might actually find none, but then if you look at another 10, the amount of expression that we see is kind of all over the place. It's not like other receptors where one tends to express a certain amount and that's the way it is in health. ACE2 doesn't seem to be that way for whatever reason. Milka Koupenova: We were able to detect in some of the people by qPCR, but what was interesting is that from the three primers that I used there was never the same person who we were able to detect all three primers with for that receptor. That tells you that maybe they are changes of one base that is not enough for the primer to detect it, right? That becomes another possibility of not being able to detect. Milka Koupenova: And so I go to confocal microscopy where I use 100 lens and tons of hours in the microscope room, and Scott is completely right, it's really hard to see it particularly in healthy people. And it starts to pick a little bit more in people with cardiovascular disease or people with COVID that are old. So it's a bit complicated, but the important thing here is, besides the fact that we are detecting ACE2 and we're detecting proteins and I use controls, biological controls to prove that this is the case and it's not just an antibody problem, is that the virus will get picked up by platelets even if you don't have ACE2. That is the take home message from this paper is that the platelet has evolved various mechanisms by which is utilizes getting it inside. It is that important for this virus. This type of virus is not recirculating. In this case, what we observed is that the virus is attached to microparticles that are of platelet origin for that matter. Cindy St. Hilaire: So really what you're saying, what I'm hearing is the platelet is the superhero of the body. Milka Koupenova: Definitely. Absolutely. No bias, absolutely. Cindy St. Hilaire: Unbiasedly, it is a superhero. Well, Dr Cameron and Dr Koupenova, thank you so much not only for this amazing discussion, but for really an elegant, elegant paper that is really bringing to light the complex interaction between SARS-CoV-2 and platelets. So thank you so much for joining me and keep publishing amazing stories like this. Milka Koupenova: Thank you for having us. Scott Cameron: Thank you, an honor to be here. Thanks again. Cindy St. Hilaire: That's it for the highlights from August 20th and September 3rd issues of Circulation Research. Thank you for listening. Please check out the CircRes Facebook page and follow us on Twitter and Instagram with the handle @CircRes and #DiscoverCircRes. Thank you to our guests, Dr Scott Cameron and Dr Milka Koupenova. This podcast is produced by Ashara Ratnayaka, edited by Melissa Stoner, and supported by the editorial team of Circulation Research. Some of the copy text for the highlighted articles is provided by Ruth Williams. I'm your host, Dr Cynthia St. Hilaire, and this is Discover CircRes, your on-the-go source for the most exciting discoveries in basic cardiovascular research. This program is copyright of the American Heart Association, 2021. The opinions expressed by speakers in this podcast are their own and not necessarily those of the editors or of the American Heart Association. For more information, please visit ahajournals.org.
Professor Alan Shihadeh, dean of the Maroun Simaan Faculty of Engineering and Architecture, explains what he and his colleagues have learned in AUB's Aerosols Research Lab over the last 20 years. From water pipe smoking to Beirut's air after the port explosion and mass use of diesel generators, aerosols are often dangerous to our health, he notes. He also talks about how the knowledge they generate can help shape public policies in Lebanon and around the world.
Jamie Hartmann-Boyce and Nicola Lindson discuss the April 2021 update to their Cochrane living review of electronic cigarettes for smoking cessation and respond to questions from listeners. Jamie Hartmann-Boyce and Nicola Lindson discuss the April 2021 update to the Cochrane living review of electronic cigarettes for smoking cessation. This podcast is a companion to this Cochrane Review and shares the evidence from monthly searches and review findings. In this episode Jamie Hartmann-Boyce and Nicola Lindson discuss the latest update to the review and respond to questions covering subjects, such as risk of bias, design of randomised control trials (RCTs), second hand vapour and sustainable cessation, put to them by listeners. This update includes six new studies that have been added since the 2020 version of the review and we are pleased to see the first inclusion of an RCT studying e-cigarette pod devices. There is still moderate certainty that nicotine containing e-cigarettes help more people to quit at 6 months or longer compared to e-cigarettes without nicotine or than NRT (nicotine replacement therapy). Uncertainty still exists around nicotine containing e-cigarettes compared to no intervention (eg continued smoking). This reflects that the quality of the evidence is considered very low according to Cochrane standards. In this update the low certainty evidence for no difference in adverse and serious adverse effects between nicotine e-cigarettes and non-nicotine e-cigarettes has been upgraded to moderate certainty evidence. Jamie and Nicola also bring us up to date with the literature search conducted on April 1st, which found one linked and two new ongoing studies. doi: 10.3390/ijerph18020430 ; ANZCTR - Registration ; https://doi.org/10.1093/ehjci/ehaa946.2359
Pediatric Insights: Advances and Innovations with Children’s Health
After pediatric pulmonologists at Children’s Health saw a spike in adolescent patients referred with unusual symptoms that resembled pneumonia and viral gastroenteritis, they set out to learn why.
George Boley LinkedIn:https://www.linkedin.com/in/george-boley-jr-a498028/Website:https://georgeboleyjr.com/Instagram:https://www.instagram.com/realgeorgeboleyjr/Twitter:https://twitter.com/georgeboleyYouTube:https://www.youtube.com/channel/UCXLVylGphQupoGNlEv3hbrw My social media links:Podcast:https://podcast.app/day-in-day-out-p832991Instagram:https://www.instagram.com/muui23LinkedIn page:https://www.linkedin.com/company/day-in-day-out-podcast/?viewAsMember=trueYouTube:https://bit.ly/2UVszCm
Nebraska lawmakers banned using electronic cigarettes and vapes indoors under the Nebraska Clean Indoor Air Act this year...starting Saturday, that rule will take effect
David A. Bluemke, MD, PhD, Editor of Radiology discusses four research articles from the May 2020 issue of Radiology. ARTICLES DISCUSSED – Biological Effects of Low-Dose Chest CT on Chromosomal DNA. Sakane et al. Radiology 2020; 295:439–445. [FULL TEXT] Pediatric Chest Radiographic and CT Findings of Electronic Cigarette or Vaping Product Use–associated Lung Injury (EVALI). Artunduaga et al. Radiology 2020; 295:430–438. [FULL TEXT] Growth and Clinical Impact of 6-mm or Larger Subsolid Nodules after 5 Years of Stability at Chest CT. Lee et al. Radiology 2020; 295:448–455. [FULL TEXT] Long-term Evolution of Hepatocellular Adenomas at MRI Follow-up. Vernuccio et al. Radiology 2020; 295:361–372. [FULL TEXT]
In episode 443, James and Mike continue with Mike Kolber and we discuss the evidence around electronic cigarettes and their use for smoking cessation. Overall, the podcast ends up being smoking hot in so many ways. Show notes Tools for Practice
Maor Sauler is joined by Drs. Samuel Chung, Matthias Salathe, and Mehmet Kesimer to discuss the article “Electronic Cigarette Vapor with Nicotine Causes Airway Mucociliary Dysfunction Preferentially via TRPA1 Receptors
Commentary by Dr. Valentin Fuster
Electronic cigarettes are dangerous and you need to know more about this reality.
There are many pros and cons to electronic cigarettes but which one outweighs the other?
Host Kevin Patton previews the newly revised HAPS Learning Outcomes for A&P, discussing the goals of the revision and samples a few of the changes. Why is noon a good time to get your flu shot? Are there neurons that actively erase memories? Vaping: why A&P teachers need to keep up with the news. 00:42 | Timing of Vaccinations 02:36 | Sponsored by HAPS 03:04 | Neurons That Erase Memory 08:22 | Sponsored by AAA 08:47 | Vaping 13:45 | Sponsored by HAPI Online Graduate Program 14:28 | Revisiting the HAPS Learning Outcomes for A&P 41:43 | Staying Connected If you cannot see or activate the audio player click here. Questions & Feedback: 1-833-LION-DEN (1-833-546-6336) Follow The A&P Professor on Twitter, Facebook, Blogger, Nuzzel, Tumblr, or Instagram! It is what we think we know already that often prevents us from learning. (Claude Bernard) Timing of Vaccinations 2 minutes With a new flu season upon us, vaccination is a timely topic. Recent research suggests that the time of day at which we receive our vaccination may influence it's effectiveness. At midday, CD8 T cells may respond more strongly than at other times of day. Immune cells called T cells multiply after vaccination in the middle of the day. (journal news article) my-ap.us/2LOv2tN The circadian clock of CD8 T cells modulates their early response to vaccination and the rhythmicity of related signaling pathways (journal research article) my-ap.us/2OkPGTY Australia Just Had a Bad Flu Season. That May Be a Warning for the U.S. (news article) my-ap.us/2OmPC6n Frequently Asked Influenza (Flu) Questions: 2019-2020 Season (CDC info) my-ap.us/33oTN5H Weekly U.S. Influenza Surveillance Report — Flu View (CDC updates) my-ap.us/326MEa2 Sponsored by HAPS 0.5 minute The Human Anatomy & Physiology Society (HAPS) is a sponsor of this podcast. You can help appreciate their support by clicking the link below and checking out the many resources and benefits found there. There are a bunch of 1-day regional workshops scattered all over the continent. There's probably one near you coming up this year (or next)! Anatomy & Physiology Society theAPprofessor.org/haps Neurons That Erase Memory 5.5 minutes New evidence suggests that there is a population of neurons that actively erase old, unimportant memories during REM sleep. Hopefully, your memories of past episodes of this podcast will be preserved (as well as the date of my birthday). Scientists Identify Neurons That Help the Brain Forget: In mice, cells in the hypothalamus clear out old memories while the animals sleep. (news article) my-ap.us/2OkxEkV REM sleep–active MCH neurons are involved in forgetting hippocampus-dependent memories (journal report) my-ap.us/2MfVyvl Sponsored by AAA 0.5 minutes A searchable transcript for this episode, as well as the captioned audiogram of this episode, are sponsored by the American Association for Anatomy (AAA) at anatomy.org. Searchable transcript Captioned audiogram Vaping 5 minutes Vaping is a timely topic, considering the emergence of vaping-induced lung injury and other vaping-related conditions. Discussing the news about vaping, which is frequently updated, is appropriate in the A&P course. Following the story over the course of a year may helps students better understand human science. Vaping Illnesses Top 1,000, C.D.C. Says (news article) my-ap.us/2MgPUZL Lung Damage From Vaping Resembles Chemical Burns, Report Says (news article) my-ap.us/2IoMZxa Vaping-Induced Lung Injury (journal editorial) my-ap.us/2MhP2UH The Health Effects of Electronic Cigarettes (journal review article) my-ap.us/2OnST5b How Vaping Nicotine Can Affect A Teenage Brain (print/audio news story) my-ap.us/32b5OvG CDC Vaping Information (search results showing current information) my-ap.us/2Mch70I A Young Man Nearly Lost His Life to Vaping (newspaper article) my-ap.us/2qfkdZn Vaping-related illness has a new name: EVALI (news article) my-ap.us/2MOaUau Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette, or Vaping, Product Use Associated Lung Injury — United States, October 2019 (CDC update) my-ap.us/33Cag6U Sponsored by HAPI Online Graduate Program 1 minute The Master of Science in Human Anatomy & Physiology Instruction—the MS-HAPI—is a graduate program for A&P teachers. A combination of science courses (enough to qualify you to teach at the college level) and courses in contemporary instructional practice, this program helps you power up your teaching. Kevin Patton is a faculty member in this program. Check it out! nycc.edu/hapi Revisting the A&P Learning Outcomes from HAPS 27 minutes HAPS recently released its revised Learning Outcomes for A&P. It's a significant revision, with many improvements. Kevin discusses some of the changes and gives advice on how to navigate and use them in your course. HAPS Learning Outcomes (download page for outcomes and white paper; requires login) my-ap.us/2noTclo Module titles: A: Body Plan & OrganizationB: HomeostasisC: Chemistry & Cell Biology D: Histology E: Integumentary System F: Skeletal System & Articulations G: Muscular System H: Nervous System I: General and Special Senses J: Endocrine System K: Cardiovascular System L: Lymphatic system and immunity M: Respiratory System N: Digestive system O: Nutrients & Metabolism P: Urinary System Q: Fluid/Electrolytes & Acid-Base Balance R: Reproductive System S: Introduction to Heredity T: Embryology If the hyperlinks here are not active, go to TAPPradio.org to find the episode page. More details at the episode page. Transcript available at the script page. Listen to any episode on your Alexa device. Need help accessing resources locked behind a paywall? Check out this advice from Episode 32 to get what you need! https://youtu.be/JU_l76JGwVw?t=440 Sponsors Transcript and captions for this episode are supported by the American Association for Anatomy. anatomy.org The Human Anatomy & Physiology Society also provides marketing support for this podcast. theAPprofessor.org/haps Distribution of this episode is supported by NYCC's online graduate program in Human Anatomy & Physiology Instruction (HAPI) nycc.edu/hapi Clicking on sponsor links helps let them know you appreciate their support of this podcast! Referrals also help defray podcasting expenses. Amazon TextExpander Snagit & Camtasia The A&P Professor Logo Items Follow The A&P Professor on Twitter, Facebook, Blogger, Nuzzel, Tumblr, or Instagram! The A&P Professor® and Lion Den® are registered trademarks of Lion Den Inc. (Kevin Patton)
From the Simplr studios in San Francisco, this is your daily briefing. IntroductionWith your E-Commerce Retail Briefing for today, Friday, October 18th, I'm Vincent Phamvan.Mega-mall, Hudson Yards, was met with skepticism. As more shoppers turn to the internet, many doubted the experiential new mall would find success.First, here are some retail headlines.Juul Slapped With Wrongful-Death Vaping Suit Juul has been at the center of controversy as vaping linked deaths have continued to rise. In what may be the first wrongful-death vaping suit, one mother is saying the company’s electronic cigarettes and nicotine cartridges were a significant factor in her 18-year-old son’s death more than a year ago. The suit was filed on October 15th in the U.S. District Court for the Northern District of California, which is where Juul’s headquarters is located.U.S. Retail Sales Fell in SeptemberU.S. retail sales fell for the first time in seven months in September. The drop suggests that manufacturing-led weakness could be spreading to the broader economy. Retail sales dropped 0.3 percent last month as households cut back spending on motor vehicles, building materials, hobbies, and online purchases. Signs of cracks in the economy’s main pillar of support ahead of the holiday season could further feed financial market fears of a sharper slowdown in economic growth. Trial Mall of the Future, Hudson Yards, Sees Success In First YearWhen the Hudson Yards mega-mall opened roughly a year ago, there were a lot of skeptics and there still are. The development is in many ways meant to be a new blueprint for a shopping mall in the twenty-first century and age of Amazon. There’s a floor dedicated to brands born online, only one department store, plenty of restaurants, co-working space, interactive art exhibits, and room to lounge outdoors. Everyone now wants to know if Hudson Yards can succeed in an age where more shoppers are turning to the internet.In an interview, Hudson said that while its a tough retail market they’re getting into, the sales numbers at Hudson Yards are phenomenal. Hudson Yards is expected to see more than 20 million visitors in its first year being open. A few retailers have already found success in the mall. Experiential store, b8ta, has been a standout among the retailers, along with luxury brands like Dior. Hudson said in a quote, “Of all the projects we are involved in, this is the most thrilling.” ClosingNeed some help for the holidays? Simplr can help you scale up your customer service with 24/7 support. Find out more at Simplr.ai. That’s S-I-M-P-L-R.ai Thanks for listening to the latest episode of the Retail E-Commerce Briefing. Tune in tomorrow for our interview with the founder of Blue Apron and Cooks Venture.
Amazon Rainforest, Eva Braun, Vybz Kartel, Skin Whitening, Sammy Sosa, Shaquille O’Neal, Shaq Fu, Wu-Tang: Shaolin Style, Margo Price, Ray J, Will.I.Am, Kim Hill (soul musician), The Black Eyed Peas, Fergie, Methamphetamine, McDonald’s, Impossible Foods, Electronic Cigarette, Vaping-associated pulmonary injury, Hookah, Opium, Opium Den, Salvia, Miley Cyrus
The Centers for Disease Control recently linked a current lung disease outbreak to electronic cigarettes (e-cigarettes) and vape devices. These devices have rapidly become the most common tobacco products used by teens, driven in large part by marketing and advertising by e-cigarette companies that market the products’ convenience of use and flavor variety. Now, however, the use of these unregulated products is landing many kids in the emergency rooms of hospitals across the country with serious lung illnesses.Dr. Ferkol joins the show to discuss the current outbreak, when a child should be seen for treatment, as well as recommendations for pediatricians and pediatric health care providers to combat tobacco use in all forms.
On today's episode:Do you vape or plan on vaping in the future? Well, tune in to hear why vaping might not be a choice for you. Electronic Cigarettes: https://www.cdc.gov/tobacco/basic_information/e-cigarettes/index.htm5 Vaping Facts You Need to Know: https://www.hopkinsmedicine.org/health/wellness-and-prevention/5-truths-you-need-to-know-about-vapingThanks for listening to The Juice Talk Radio Podcast!
Today on Sober Grind We chat about the dangers of vaping and electronic cigarettes! It's in the news and in your thoughts! So, let's talk about this!Sober Grind is an addiction recovery podcast dedicated to highlighting the most interesting topics and intriguing guests about all things recovery!Email us your topic ideas, questions, or if you'd like to share your recovery story at austin@beginningstreatment.comCheck out our brand new website! www.SoberGrind.comDo you like this show and want to help us grow and impact more lives? Please consider leaving us a review on iTunes and subscribing!Join our amazing Facebook Recovery CommunitySubscribe and listen to Sober Grind onItunes Google Play iHeart RadioCall today to get help with addiction: 800-387-6907
Are electronic cigarettes really a healthier alternative to tobacco products? Risa Robinson, head of RIT’s department of mechanical engineering, talks with Edward Hensel, associate dean, about their unique research methods into how these devices are used and how they affect users’ health. Read a transcript of this podcast: https://www.rit.edu/sites/rit.edu/files/docs/E-Cig%20podcast%20transcript.pdf.
I have a few e-cigs laying around... --- Send in a voice message: https://anchor.fm/mcl771/message
Dr. Morrow’s Show Notes on Vaping If we are going to talk about vaping, we have to talk about: NICOTINE. Why nicotine? What does it do to your brain? Nicotine activates the circuitry that regulates feelings of pleasure, the so-called reward pathways. Research has shown that nicotine increases the levels of dopamine (a key brain chemical involved […] The post To Your Health With Dr. Jim Morrow: Episode 4, Vaping appeared first on Business RadioX ®.
Rob Black talks about de-risking, England, electronic cigarettes, Twitter, WKRP, Thanksgiving, and chats with CFP Chad Burton about online retirement tests.See omnystudio.com/listener for privacy information.
Vaping and electronic cigarettes (e-cigarettes) are battery-operated devices which produce an aerosolized mixture from a solution of concentrated nicotine, flavoring chemicals, and other substances to be inhaled by the user. These devices have exploded in popularity over the last several years, largely due to aggressive marketing and advertising that include unsubstantiated claims of e-cigarettes as “healthier” than conventional cigarettes. This presentation will highlight the current scientific evidence on electronic cigarettes and the impact on youth tobacco use, health and public health effects.
This week’s subreddit is unfortunately the vaping haven of e-cigs. Matt loves bread, Louisa loves milk, Jeff loves nothing at all. Please rate, review, and subscribe to our podcast and follow us on Twitter @SeeingReddit or e-mail us at SeeingReddit@gmail.com! Tell your friends if you enjoy the show – we’re always happy to offend new listeners! Our […]
In this episode, Sal, Adam & Justin speak with Jeremy Green, Chief Operations Officer of Dosist, an innovative cannabis company that is delivering the therapeutic value of cannabis to people using their unique pen that electronically delivers the perfect dose every time. From electronics to cannabis. How Jeremy got into the industry and the origins of dosage control? (5:38) What was the “Ah-Ha” moment he experienced that he had something here? (12:20) He shares a personal account of why he got into cannabis and how it has benefited his life. (13:32) What fears did he have getting into the cannabis market? (16:35) How he used his engineering background to do the research on learning the best oil production process. (23:20) How does their pen provide an equal dose experience each time? (27:40) The science of the extraction process, their compliance practices and how they separate themselves from the crowd. (33:40) The bad stigma of going to a dispensary and their legitimacy. (38:44) The Need State Concept, quality control and the design of their product for the masses. How what Mind Pump did for fitness, Dosist is doing for cannabis. (46:30) How strains are influenced by the terpenes in them. (58:00) What has the feedback been like so far? (1:08:40) Why is there is lack of knowledge of cannabinoids, their focus on education and how did they get their funding? (1:11:15) Plans for expansion and growth? (1:17:50) The descriptions of their various pens they offer and their uses. (1:20:00) How it takes experimentation to find what works best for you. (1:25:50) Featured Guest dosist – delivering health and happiness™ - http://dosist.com/ Related Links/Products Mentioned Historical Timeline of Electronic Cigarettes - http://www.casaa.org/historical-timeline-of-electronic-cigarettes/ Opioid Use Lower In States That Eased Marijuana Laws - https://www.npr.org/sections/health-shots/2018/04/02/598787768/opioid-use-lower-in-states-that-eased-marijuana-laws FDA's Deeming Regulations for E-Cigarettes, Cigars, and All Other Tobacco Products - https://www.fda.gov/TobaccoProducts/Labeling/RulesRegulationsGuidance/ucm394909.htm Does the Regulatory Environment for E-Cigarettes Influence the Effectiveness of E-Cigarettes for Smoking Cessation?: Longitudinal Findings From the ITC Four Country Survey - https://academic.oup.com/ntr/article/19/11/1268/3061874 FDA deeming rule: A step forward, especially if the FDA acts quickly on the advertising rules and educational campaign - https://tobacco.ucsf.edu/fda-deeming-rule-step-forward-especially-if-fda-acts-quickly-advertising-rules-and-educational-campaign Lab results - http://dosist.com/lab-results/ MedMen Cannabis Dispensaries - https://medmen.com/ Airfield Supply Co. - http://www.airfieldsupplyco.com/ The Bespoke High Is the Future of Marijuana - The Atlantic - https://www.theatlantic.com/health/archive/2017/06/hmbldt-weed-pen/530832/ Anomaly - http://anomaly.com/ Formulas - http://dosist.com/formulas/ Cornerstone Research Collective - https://cornerstonecollective.com/ Winners of the 2017 SoCal Harvest Cup – dosist - https://dosist.com/winners-of-the-2017-socal-harvest-cup/ Would you like to be coached by Sal, Adam & Justin? You can get 30 days of virtual coaching from them for FREE at www.mindpumpmedia.com. Get our newest program, MAPS HIIT, an expertly programmed and phased High Intensity Interval Training program designed to maximize fat burn and improve conditioning. Get it at www.mindpumpmedia.com! Get MAPS Prime, MAPS Anywhere, MAPS Anabolic, MAPS Performance, MAPS Aesthetic, the Butt Builder Blueprint, the Sexy Athlete Mod AND KB4A (The MAPS Super Bundle) packaged together at a substantial DISCOUNT at www.mindpumpmedia.com. Make EVERY workout better with MAPS Prime, the only pre-workout you need… it is now available at mindpumpmedia.com Also check out Thrive Market! Thrive Market makes purchasing organic, non-GMO affordable. With prices up to 50% off retail, Thrive Market blows away most conventional, non-organic foods. PLUS, they offer a NO RISK way to get started which includes: 1. One FREE month's membership 2. $20 Off your first three purchases of $49 or more (That's $60 off total!) 3. Free shipping on orders of $49 or more You insure your car but do you insure YOU? If you don't, and you are the primary breadwinner, you will likely leave your loved ones facing hardship and struggle if you die (harsh reality). Perhaps you think life insurance is expensive, but if you are fit and healthy, you can qualify for approved rates that are truly inexpensive and affordable. To find out if you qualify for the best rates in the industry, go get a quote at www.HealthIQ.com/mindpump Have Sal, Adam & Justin personally train you via video instruction on our YouTube channel, Mind Pump TV. Be sure to Subscribe for updates. Get your Kimera Koffee at www.kimerakoffee.com, code "mindpump" for 10% off! Get Organifi, certified organic greens, protein, probiotics, etc at www.organifi.com Use the code “mindpump” for 20% off. Go to foursigmatic.com/mindpump and use the discount code “mindpump” for 15% off of your first order of health & energy boosting mushroom products. Add to the incredible brain enhancing effect of Kimera Koffee with www.brain.fm/mindpump 10 Free sessions! Music for the brain for incredible focus, sleep and naps! Also includes 20% if you purchase! Please subscribe, rate and review this show! Each week our favorite reviewers are announced on the show and sent Mind Pump T-shirts! Have questions for Mind Pump? Each Monday on Instagram (@mindpumpmedia) look for the QUAH post and input your question there. (Sal, Adam & Justin will answer as many questions as they can)
Electronic cigarettes are used almost as much as conventional cigarettes in some parts of the world and are particularly popular among young people. They are often advertised as a means of stopping smoking but there is a lack of consistent evidence for this claim. In this episode, we hear from Dr. Man Pin Wang from the School of nursing, University of Hong Kong. He and his team performed a longitudinal study of adolescents that called the Youth Quitline in Hong Kong, in order to investigate the links between e-cigs and quitting smoking in this population. See acast.com/privacy for privacy and opt-out information.
Independent, investigative news, reporting, interviews and commentary
Independent, investigative news, reporting, interviews and commentary
The LeRoy Butler of episodes, we got a good one for you. We bypass the Artist Corner this week to discuss the abrupt ending of a certain concert in Queens New York. We combine a few of our segments (Politics/Global/USA) into a single News Segment, and this week we discuss the presidential debates. We join Dan Patrick and the Dannettes on the discussion on whether SportsCenter should be a top 100 greatest TV Show of all time? There's a critique of the new Netflix series Stranger Things. In our new Relationship Goals segment, we discuss whether CatCalling is wrong, and how else can you go about complimenting a woman? Also, E-cigs are the worst thing that happened to a Hogwart's ride. All that and more on this week's episode of Wisco Goes West.
In this cross-sectional study of grade 9 students in the Niagara region of Ontario, reported use of e-cigarettes was common and associated with potential risk factors, including exposure to use of tobacco by family members and friends, and personal tobacco use. Most teens reported trying e-cigarettes because it was cool/fun/new rather than for smoking reduction or cessation. Dr. Michael Khoury, paediatric cardiology resident at the Hospital for Sick Children in Toronto, discusses the CMAJ research article he co-authored. Full research article (open access): www.cmaj.ca/lookup/doi/10.1503/cmaj.151169 ----------------------------------- Subscribe to CMAJ Podcasts on iTunes, Stitcher, Overcast, Instacast, or your favourite aggregator. You can also follow us directly on our SoundCloud page. Our podcasts are also released on www.cmaj.ca and on www.cmajblogs.com.
Independent investigative journalism, broadcasting, trouble-making and muckraking with Brad Friedman of BradBlog.com
Independent investigative journalism, broadcasting, trouble-making and muckraking with Brad Friedman of BradBlog.com
Dr. Amy Fairchild is a professor of sociomedical sciences at the Columbia University Mailman School of Public Health. Stephen Morrissey, the interviewer, is the Managing Editor of the Journal. S.H. Green, R. Bayer, and A.L. Fairchild. Evidence, Policy, and E-Cigarettes - Will England Reframe the Debate? N Engl J Med 2016;374:1301-3.
Brett Kelly writes about technology, efficiency, business and Evernote. You can spend hours and hours of your precious free time on experimentation and trial-and-error, trying to find the best way to make Evernote work for you. Or you can pick up Evernote Essentials and learn from the expert in an afternoon. In fact Brett used to work at Evernote until just recently. Mentioned in this episode: Brett’s 1st appearance on this show Evernote Essentials Master Your Mac The Art and Science of Vaping: A Beginner’s Guide to Electronic Cigarettes Please connect with me Subscribe, rate, and review in iTunes Follow @ErikJFisher Check out more Noodle.mx Network showsThe Audacity to Podcast: "How-to" podcast about podcastingBeyond the To-Do List: Personal and professional productivityThe Productive Woman: Productivity for busy womenONCE: Once Upon a Time podcastWelcome to Level Seven: Agents of SHIELD and Marvel’s cinematic universe podcastAre You Just Watching?: Movie reviews with Christian critical thinkingthe Ramen Noodle: Family-friendly clean comedy
[Read the Article] Electronic cigarettes (e-cigarettes) are becoming increasingly popular among teens. A new study looks at whether younger teens who never smoked cigarettes and who begin using e-cigarettes might be more likely to go on to use conventional tobacco products.Researchers from the University of Southern California, Los Angeles surveyed more than 2,300 Los Angeles area high school students who reported never using tobacco products at the beginning of 9th grade. The students were surveyed again six months later and also when entering the 10th grade.In a comparison of teens who had used e-cigarettes to those who had not, the researchers found that those who had used e-cigarettes were four times more likely to have gone on to use conventional tobacco products, including cigarettes and cigars. The researchers acknowledge that their findings, while suggestive, cannot prove that e-cigarette use directly causes subsequent tobacco use. [Watch more videos of The JAMA Report] JAMA Report videos provided pursuant to license. ©2015 American Medical Association, publisher of JAMA® and The JAMA Network® journals.
Independent investigative journalism, broadcasting, trouble-making and muckraking with Brad Friedman of BradBlog.com
Independent investigative journalism, broadcasting, trouble-making and muckraking with Brad Friedman of BradBlog.com
Interview with Adam M. Leventhal, PhD, author of Association of Electronic Cigarette Use With Initiation of Combustible Tobacco Product Smoking in Early Adolescence
We are meeting with Nick Molina, CEO of VaporFi. VaporFi is a leader in the E-Cigarette and Vapor industry is on a mission to change the way you smoke. VaporFi retail Stores cater to a wide range of vape enthusiasts, from those curious about ditching tobacco to those advanced techy vapers who are the true hobbyists. VaporFi’s exclusive, proprietary and branded product line has taken the world by storm. Their E-Cig products provide all the pleasures of traditional smoking without the bad breath, stinky clothes, tremendous cost, and harmful effects of tobacco.
This podcast highlights a state of the art review published in the July 2015 issue of Otolaryngology - Head and Neck Surgery, the official journal of the American Academy of Otolaryngology - Head and Neck Surgery (AAO-HNS) Foundation. Editor in chief John Krouse is joined by senior author Ryan Bransky and associate editor Cristina Baldassari in discussing the growing use of electronic cigarettes in the United States. Over the past decade there has been a rapid expansion in the use of and types of electronic cigarettes, or e-cigarettes, among the US population. In 2009 less than 1% of the American population had tried using e-cigarettes, and by 2013 over 8% of Americans had used them. The sales of e-cigarettes are predicted to surpass $10 billion by 2017. There has also been a rapid expansion in use among teenagers, who enter the use of oral nicotine in early life as their first cigarette experience through “vaping.” There are establishments that are dedicated to the use of these products, and this use is currently unregulated. Drs. Bransky and Baldassari discuss the implications of this rapid growth in electronic cigarettes, especially among children during their school-age years, and look at the range of potential concerns for both present and future use. Click here to read the full article.
Electronic Cigarettes have been hailed by some as a breakthrough in the battle to help people quit smoking, while others say these devices are creating a new generation of nicotine addicts. So, what does the science say?
Attorney Azim Chowdhury has developed expertise in tobacco and e-vapor product regulation relating to the implementation of the Family Smoking Prevention and Tobacco Control Act, and spearheaded the FDA Tobacco and Electronic Cigarette practice at Keller and Heckman http://www.khlaw.com/Azim-Chowdhury Also joined by VISTA president Kevin Skipper discussing state legislation and my media wtf moment of zen
Interview with Sharon A. McGrath-Morrow, MD, MBA, author of Electronic Cigarette Use and Exposure in the Pediatric Population
Reading by Jessica Barrington-Trimis, PhD, MS, MA, author of Flavorings in Electronic Cigarettes: An Unrecognized Respiratory Health Hazard?
Mass Extinction! 250 million years ago nearly all life on Earth ended. Back from the brink, history then repeated itself with the disappearance of the dinosaurs 60 million years ago. So are we next? Plus news of how a comet smash could have kick-started life on Earth, whether e-cigarettes are safe, and why science and medical reporting in the media might be untrustworthy... Like this podcast? Please help us by supporting the Naked Scientists
Mass Extinction! 250 million years ago nearly all life on Earth ended. Back from the brink, history then repeated itself with the disappearance of the dinosaurs 60 million years ago. So are we next? Plus news of how a comet smash could have kick-started life on Earth, whether e-cigarettes are safe, and why science and medical reporting in the media might be untrustworthy... Like this podcast? Please help us by supporting the Naked Scientists
England might be out of the World Cup this week, but thousands of fans are still cheering their teams on across Brazil. But how does chanting change the behaviour of a football crowd? Why do free kicks and penalties still come down to good old physics? And how can economists use data from the pitch to see whether discrimination still exists in the beatuiful game? Plus, in the news, why scientists have blown up a mountain in Chile, why you could get addicted to sunshine, and are electronic cigarettes safe? Like this podcast? Please help us by supporting the Naked Scientists
England might be out of the World Cup this week, but thousands of fans are still cheering their teams on across Brazil. But how does chanting change the behaviour of a football crowd? Why do free kicks and penalties still come down to good old physics? And how can economists use data from the pitch to see whether discrimination still exists in the beatuiful game? Plus, in the news, why scientists have blown up a mountain in Chile, why you could get addicted to sunshine, and are electronic cigarettes safe? Like this podcast? Please help us by supporting the Naked Scientists
Researchers have long known that nicotine has a beneficial effect on reducing the symptoms of schizophrenia. Over 90% of schizophrenics smoke. Our guest Helen Redmond discusses the benefits of e-cigarettes as a safe nicotine delivery device for schizophrenics. Redmond is the author of the article Here’s Why We Should Give E-Cigarettes to Mentally Ill People.
Claim Your Excellent Life| Happiness | Self Esteem | Relaxation | Relationships
Learn what the latest scientific studies say about electronic cigarettes.
Associated article:
The VP Live Vape Team was LIVE at ECC 2013! We bring you the great vendors, products, and people presented last weekend at the Anaheim Convention Center in Anaheim, California! Over two days over 15,000 people came to experience the California vaping culture. All vendors and products shown are linked here: http://bit.ly/172jw2W Thanks to everyone who made ECC2013 possible and everyone who helped with this broadcast. Stay tuned for information about ECC 2014 at http://www.ecc-expo.com Find more information about the Vape Team at: Our Website: http://www.vapeteam.com Facebook: http://www.facebook.com/vapeteam Google+: http://gplus.to/vapeteam Twitter: http://www.twitter.com/vapeteam DISCLAIMER: VPLive Vape Team is an opinion based video talk show and podcast about the vaping and electronic cigarette community. As such, all views and opinions expressed herein, regardless of authorship, do not represent the views or opinions of any presenter's employer or people, institutions or organizations that the presenter may or may not be related to or affiliated with unless explicitly stated otherwise. All contributors on VPLive Vape Team are non paid, independent vapers, or when specifically stated, representatives of electronic cigarette vendors. The only purpose of this program is to educate and to inform. It is no substitute for professional care by a doctor or other qualified medical professional. This program is provided on the understanding that it does not constitute medical or other professional advice or services. Instead, we encourage you to discuss your options with your healthcare provider. This podcast is intended to be viewed by adults of legal smoking age. It is not intended for viewers under the age of 18. Full Disclosure: CJ, the Vaping Monkey, is the owner of VapingMonkey.com and VaperVenue, a web and brick and mortar vaping shop based in Southern California (http://www.vapervenue.com)
What are the relative risks of e-cigarettes, nicotine patches and snuff? Like this podcast? Please help us by supporting the Naked Scientists
On VPLive Vape Team Episode #81: “What the Law Says” Our guest Cindy Lanning joins us with an announcement, as we analyze where vaping currently stands - from the Canadian perspective, as well as in the greater context of the global war on vaping. We'll discuss effective vs ineffective approaches and about what needs to be known and done to win the fight. In the “New Vapers Corner” Uncle Dagger breaks down micro coils and Dimi reviews the INNOKIN 134 "Machine Gun Mod" Bit.ly Bookmarks Bundle for this show, links to everything we talked about, including Vapemeets: http://bit.ly/vt81links Have a Roku Box? Want to watch the Vape Team on it? Check this out: http://youtu.be/2YZOwa_DiIc We are now broadcasting on YouTube Live! Check out the show stream on Wednesday nights! Shoutouts: Health Canada is engaged in one of the largest propaganda campaigns in health history in Canada, they keep saying that eliquid with nicotine is illegal in Canada… But is it really? Thank you to Cindy from Rainbow Vapor (http://www.rainbowvapor.com) for starting "What Does the Law Say", a web site that explains the legalities of electronic cigarettes and e-liquid in Canada. If you are a Canadian, please check out the site, read the laws, and get informed. Check it out at http://www.whatdoesthelawsay.ca Thanks to Matthew Stanko from Canadians Advocating Vapers Rights for calling in to discuss how the group is going to change the perception of electronic cigarettes and nicotine based e-liquid in Canada. If you want to fight for truth and fair vaping legislation in Canada, check out their Facebook group. https://www.facebook.com/groups/canadiansadvocatingvapersrights/ Thanks to FluidVaper for giving away an amazing CYBORG mod on the show tonight. The DNA20 based modular tube mod is one of the hottest new devices on the market and retails for $250, thanks for a great prize! Check them out at http://www.fluidvaper.com Thanks to House of Vapor for letting us give away a INNOKIN 134 after our review tonight. Check out Andre (the 6th best hair in vaping) at http://www.thehouseofvapor.com Supporting Vendors: FluidVapor - http://www.fluidvapor.com Halo Cigs - http://www.halocigs.com The House of Vapor - http://www.thehouseofvapor.com PBDragon - http://www.pbdragon.com VapeFX - http://www.vapefx.com Legal Updates and News: CASAA: Vero council delays vote to ban flavored tobacco (including e-cigarettes) http://bit.ly/18LlPGC 9News: Fort Collins smoking ban could extend outdoors http://bit.ly/ftcolinsoutdoorban Gothamist: Bloomberg Is Trying To Snuff Out Your E-Cigs http://bit.ly/nycgothamist Fox9 Twin Cities: Smoking and Electronic Cigarettes at the Minnesota State Fair http://bit.ly/mnstatefair The New Vapers Corner: The Innokin 134 http://www.innokin.com/itaste134.html Find more information about the Vape Team at: Our Website: http://www.vapeteam.com Facebook: http://www.facebook.com/vapeteam Google+: http://gplus.to/vapeteam Twitter: http://www.twitter.com/vapeteam DISCLAIMER: VPLive Vape Team is an opinion based video talk show and podcast about the vaping and electronic cigarette community. As such, all views and opinions expressed herein, regardless of authorship, do not represent the views or opinions of any presenter's employer or people, institutions or organizations that the presenter may or may not be related to or affiliated with unless explicitly stated otherwise. All contributors on VPLive Vape Team are non paid, independent vapers, or when specifically stated, representatives of electronic cigarette vendors. The only purpose of this program is to educate and to inform. It is no substitute for professional care by a doctor or other qualified medical professional. This program is provided on the understanding that it does not constitute medical or other professional advice or services. Instead, we encourage you to discuss your options with your healthcare provider. This podcast is intended to be viewed by adults of legal smoking age. It is not intended for viewers under the age of 18. Full Disclosure: CJ, the Vaping Monkey, is the owner of VapingMonkey.com and VaperVenue, a web and brick and mortar vaping shop based in Southern California (http://www.vapervenue.com)
Interview with Neal L. Benowitz, MD, author of The Regulatory Challenge of Electronic Cigarettes
I, Electronic Cigarette An electronic cigarette wrote an essay about how remarkable he is, and the way the world should work. Jason Cropper, founder of Totally Wicked cancelled his interview, but wrote me an email explaining why, and his opinion of the motive behind why he was attacked and robbed. Tim from RY4 Radio in the UK calls in to give his opinion on the matter. Lots of confusion regarding the proposed NYC ecig ban. http://blog.casaa.org/2013/04/call-to-action-new-york-city-ordinances.html My document calling out politicians kinda went viral: http://www.scribd.com/doc/159186684/NYC-Ecig-Ban Faxing legislators is fun! http://imgur.com/qLCat0X Russ reviews http://bkdelivers.com - Burger King's new home delivery service An update on the vaping whistleblower and the Southern California B&M stings. Matt's "fight for your right to vape daily action plan": http://www.e-cigarette-forum.com/forum/general-e-smoking-discussion/455100-fight-your-right-vape-daily-action-plan-tuesday-8-13-13-hearing-sb-648-tomorrow-time-take-action.html http://vapersplace.com/takeaction mamu is going to give away a Stealthy DNA-20 mod on an upcoming episode of Click, Bang! oh yays!
The afterhours portion of the broadcast.
April 24, 2013 Podcast: Electronic cigarette health, the best sleeping position, how to recover from pneumonia, exercising in pollution, how to make bulletproof coffee, when to use olive oil and when to use coconut oil, and supplements for beta cells. Click To Subscribe To All Ben's Fitness Tips & Get A Free Surprise Gift From Ben. Have a podcast question for Ben? Click the tab on the right side of this page, call 1-877-209-9439, Skype “pacificfit” or (if you hate the sound of your own voice) scroll down to the “Ask Ben” form. Please don't forget to give the podcast a comment/ranking in iTunes - it only takes a minute and it helps grow our healthy and fit community! ----------------------------------------------------- News Flashes: To get these and a few other illuminating news flashes each and every week, follow Ben on Twitter.com/BenGreenfield, Facebook.com/BGFitness and Google+. Another good reason NOT to static stretch before your workout. If you have the choice to run in sand vs. running in grass, sand is better for getting fitter. Of note to those concerned about low carb diets/glycogen stores, protein does indeed replace glycogen stores. ----------------------------------------------------- Special Announcements: If you're looking for a topic we covered in the past - we have released the Ben Greenfield Fitness Top Hits, Vol. 1. Including: 1. The Benefits of Fish vs. Fish Oil 2. The Best Ways to Stop Hair Loss 3. Increase Your Hematocrit & Oxygen Levels 4. Strengthen Your Immune System & Shorten the Duration of a Cold 5. Top 10 Ways to Boost Libido 6. Get Rid of Migraines Naturally 7. Become a Curvaceous, Lean, Ripped Female Athlete Without Destroying Your Health 8. Stop Side Stitches as Fast as Possible 9. Is It Possible for a Vegan to Be a Healthy Endurance Athlete 10. How Much Water Do You Really Need to Drink Each Day 2013 Thailand Triathlon Adventure with Ben Greenfield - details at pacificfit.net. Ask Ben Anything About Minimalist Triathlon Training - Saturday April 27, 6pm PDT. Go to BenGreenfieldFitness.com/innercircle to get your Spreecast access. Essentials of Triathlon Workshop with Ben Greenfield - Saturday, May 18, 2013 in Stamford, Connecticut. In this private clinic you'll discover everything you need to know about how to maximize your triathlon success, including Ben's top secrets, tips and tricks to save time, get the most bang-for-your-training buck, and ensure your body, health and hormones are optimized for endurance. Location: Stamford, Connecticut. - Hour 1: Essentials of Triathlon Fueling + Nutrition Q&A - Hour 2: Essentials of Triathlon Training + Workout Q&A Registration: Early bird (by May 1): $40, May 1-17: $50, At-Door Registration: $60. Reserve your spot now. Space is limited! ----------------------------------------------------- Listener Q&A: As compiled, edited and sometimes read by Brock, the Ben Greenfield Fitness Podcast "sidekick". Anne asks @ 00:22:56 She is wondering if there could be any negative effects associated with second hand "smoke" from electronic cigarettes? Her boss smokes them around her all the time in enclosed areas. Anonymous asks @ 00:28:17 Which sleeping position - back, side or stomach - is the best for rest and recovery for athletes? ~ In my response I mention Esther Gokhale's book: 8 Steps To A Pain-Free Back, this study and a previous podcast we did on the best mattress. James says @ 00:36:04 Recently came down with pneumonia which has killed his race season and has been warned to take it easy and give himself time to heal. He has finished a course of on antibiotics and then immediately started taking probiotics, oil of oregano and fish oil. His biggest issue right now is his lung capacity and shortness of breath. He wants to know what he can do to get healthy as quickly as possible. ~ This question is answered in part by a track from the iTunes album Ben Greenfield Fitness Top Hits, Vol. 1. Julius asks @ 00:50:23 His nephew recently moved from Indiana to Beijing. Can you recommend what to do when you are an outdoor runner who lives in a highly polluted city like Beijing or Hong Kong? ~ In my response, I recommend Dr. Todd's antioxidants talk at Superhuman Live event, the podcast episode How Your Cells Talk To Each Other, and LifeShotz. David asks @ 01:04:34 He recently switched from Olive Oil to Coconut Oil for most of his cooking and is wondering how much he should be consuming. He is mixing about a tablespoon into his morning cappuccino - is that too much? He is also wondering about the smoke point. He has read that Olive and Coconut Oil have about the same smoke point. Is that true? ~ In my response, I reference this smoke point chart, Nutive extra virgin coconut oil, and also bulletproof coffee. Jim asks @ 01:16:56 Ben talks about using supplements to maintain low blood sugar and promote liver health but are there any supplements that support the pancreas and help maintain healthy beta cells. ~ In my response to Jim, I recommend MPX100 and Thermofactor. Prior to asking your question, do a search in upper right hand corner of this website for the keywords associated with your question. Many of the questions we receive have already been answered here at Ben Greenfield Fitness!
On VPLive Vape Team Episode #67: "Vaping Reality" - On this episode, a special Ten@10 with our guests from the Vapor World Order! In the “Vaping News” the balanced perspective of the PLOS ONE Cartomizer study and in the “New Vapers Corner” an SVD Update and the Piculisci Tiny Genesis Atomizer. Finally the judges have decided and we are giving away the AquaVapor Ecig Wholesaler Package to a lucky winner. Bit.ly Bookmarks Bundle for this show, links to everything we talked about, including Vapemeets: http://bit.ly/vt67links Have a Roku Box? Want to watch the Vape Team on it? Check this out: http://youtu.be/2YZOwa_DiIc Shout Outs: We hate to start off the show in this tone, but it is the least we can do to honor the memory of a good friend lost too soon. Vasilis Stivaktakis was only 35 yrs old when he was tragically killed in a motorcycle accident in Athens Greece this past Friday. Vasili leaves behind hundreds of friends that not only appreciated his work in the vaping community but his kindness and willingness to help anyone in need. Most importantly he leaves behind his wife and 11 month old son which he always talked to us about proudly. Even though we cannot bring him back we can comfort his family, especially in difficult economic times that Greece is going thru these days. The VP Live network has setup a GoGetFunding account to raise some money for them. Also the APV and Modding community has done a tremendous job with raffles, modders and vapers donating devices for the same cause. http://bit.ly/donatetovasilis Thanks to CJ and Andrew from Vapor Trail and the Vaping World Order http://www.youtube.com/wnyvapor http://www.vaportrailonline.com http://www.facebook.com/wnyvapor https://www.twitter.com/wnyvapor Thanks to Phil Busardo for coming on the air, you can find more information and his great video reviews at: http://www.tasteyourjuice.com http://www.youtube.com/pbusardo Supporting Vendors: Thanks to the vendors who gave us great prizes to give away to our audience on this episode! They help us out, so check them out! Clouds of Vapor - http://www.cloudsofvapor.com iVape - http://www.ivape.net PBDragon - http://www.pbdragon.com Smartvapes - http://www.smartvapes.com The New Vapers Corner: The Innokin SVD (Production Model) http://bit.ly/innokinsvd Piculisci Genesis Atomizer by Scientist http://bit.ly/16xth7C Stainless Steel Smoktech Groove http://bit.ly/10zShWs In The News: Metal and Silicate Particles Including Nanoparticles Are Present in Electronic Cigarette Cartomizer Fluid and Aerosol PLOS One: http://bit.ly/plosecigstudy New Study Sounds Alarm about Metals Detected in Electronic Cigarettes, But Fails to Inform Readers that Nicotine Inhalers Have Similar Levels of the Same Metals The Rest of the Story Blog: http://bit.ly/rotsmetals Nicotine Replacement Therapy Labels May Change FDA: http://bit.ly/fdaonthrlabels Volcano Ecigs Cigarette Butt Beach Clean Up Honolulu YouTube: http://bit.ly/volcanobeach Find more information about the Vape Team at: Our Website: http://www.vapeteam.com Facebook: http://www.facebook.com/vapeteam Google+: http://gplus.to/vapeteam Twitter: http://www.twitter.com/vapeteam DISCLAIMER: VPLive Vape Team is an opinion based video talk show and podcast about the vaping and electronic cigarette community. As such, all views and opinions expressed herein, regardless of authorship, do not represent the views or opinions of any presenter's employer or people, institutions or organizations that the presenter may or may not be related to or affiliated with unless explicitly stated otherwise. All contributors on VPLive Vape Team are non paid, independent vapers, or when specifically stated, representatives of electronic cigarette vendors. The only purpose of this program is to educate and to inform. It is no substitute for professional care by a doctor or other qualified medical professional. This program is provided on the understanding that it does not constitute medical or other professional advice or services. Instead, we encourage you to discuss your options with your healthcare provider. This podcast is intended to be viewed by adults of legal smoking age. It is not intended for viewers under the age of 18. Full Disclosure: CJ, the Vaping Monkey, is the owner of VapingMonkey.com and VaperVenue, a web and brick and mortar vaping shop based in Southern California (http://www.vapervenue.com)
Listen in to a roundtable discussion covering a mish-mash of issues related to the electronic cigarette industry.Guests include the founder of TheVaporRevolution, Raymond Polidori (co-founder of ECCR) and other avid electronic cigarette users.Topics include: - What to look for when you're buying an electronic cigarette - Struggles the Electronic Cigarette industry is facing - The future of vaping - and much more!If you are a smoker and are looking for an alternative, this is one podcast you won't want to miss. Good info, good fun!
Our guest this evening is Gilbert Ross MD, Executive Director of the American Council on Science and Health. Dr. Ross is the author of the Forbes article How Health Regulators Are Killing American Smokers. We will be discussing various tobacco harm reduction strategies including Swedish snus, electronic cigarettes, and smoking reduction.
In today's Wellness Minute Dr Fitness and the Fat Guy explain electronic cigarettes. Listen right now to hear Dr Fitness' tips. Dr Fitness and the Fat Guy's Wellness Minutes improve your health in 3 minutes a day or less. iTunes Follow us on Twitter @FatGuy and @DrFitness6 Be our Friend on Facebook
Hi and welcome to the milestogodrugeducation.com podcast where we simplify a complex subject while giving you News for your classroom. Each day we simplify current scientific news reports and studies about drugs, drug abuse and prevention on our twitter news page. Several times per month we will provide you with these drug fact updates as an audio podcast and blog which will be available on our website as well as itunes and podbean. SAMHSA study shows Asians born in the U.S. more likely to use drugs and alcohol than Asians born outside the US. http://www.jointogether.org/news/research/summaries/2010/all-asian-americans-not.html http://www.samhsa.gov/newsroom/advisories/1005192854.aspx SAMHSA study shows that Japanese Americans 3x’s more likely to use illicit drugs than families from India. http://www.jointogether.org/news/research/summaries/2010/all-asian-americans-not.html http://www.samhsa.gov/newsroom/advisories/1005192854.aspx SAMHSA study shows that Asian American binge drinking patterns vary by country and birth place w/ Korean highest. http://www.jointogether.org/news/research/summaries/2010/all-asian-americans-not.html http://www.samhsa.gov/newsroom/advisories/1005192854.aspx A small study from Geneva, Switz. Electronic Cigarettes used to quit smoking helpful, but urgent studies needed for toxicity. http://www.biomedcentral.com/1471-2458/10/231/abstract http://www.jointogether.org/news/research/summaries/2010/e-cigarettes-some-help-in.html UCLA: small study-sensitivity to the dopamine reward system of the teen brain makes it more prone to risk taking & reward seeking. http://www.jointogether.org/news/research/summaries/2010/teens-may-be-more-sensitive.html http://www.nature.com/neuro/journal/v13/n6/abs/nn.2558.html
WHO says there is no evidence that the electronic cigarette helps smokers to quit smoking. WHO this week asked manufacturers and marketers to stop their unproved therapy claims.